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Abstract of thesis entitled: 
The use of antibiotics in the medical wards of a teaching hospital in Hong Kong 
Submitted by CHONG, Kam Lin for the degree of Master of Philosophy at The 
Chinese University of Hong Kong in December 2002 
The present study involved extensive review of current literature regarding the 
epidemiology of antibiotic use and collection of data through examination of patients' 
case notes, in an attempt to document the prescribing patterns of antibiotics and the 
change of antibiotic treatment in medical wards of the Prince of Wales Hospital. In 
my study, I divided an antibiotic course into two parts, namely initial and switch 
therapies, so that antibiotic changes could be recorded and analyzed. An antibiotic 
guideline was developed based on a number of authoritative guidelines being used in 
Australia and Britain. This reference guideline served as a standard of comparison 
to examine the problems of antibiotic use. Appropriateness of antibiotic therapies 
was measured as the percentage of antibiotic therapies which adhered to the guideline. 
Following the methodology of study in the United States, therapies without 
indications recorded in patients' case notes were considered to be inappropriate. 
During a 2-month study period, 324 initial therapies and 200 switch therapies were 
classified. Cefuroxime (Zinnat® and Zinacef®) was the most frequently prescribed 
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antibiotic. In initial therapy, 39.0% were cefuroxime and in switch therapy, 
cefuroxime accounted for 34.6% of total antibiotics. Antibiotics were most 
frequently prescribed to treat infections in the lower respiratory tract (58.6%), 
followed by sepsis (8.2%) and urinary tract infection (5.1%). Average length of stay 
were 9.4 ± 7 . 8 days and up to 4 changes were recorded in an antibiotic course. 
Types of change were change of antibiotic (42%), change of route of administration 
from IV to PO (41%), addition of new antibiotic (12%), change in dosage and 
frequency (4%) and change from PO route to IV route (2%). Causes of change 
included symptomatic improvement after receiving antibiotic (45.5%), not responding 
to antibiotic treatment (25.5%), susceptibility test results suggesting alternative 
treatment (9.5%), grand round review suggesting alternative treatment (7.5%) and so 
on. The change of antibiotic treatment was as follows: Physicians generally 
responded to treatment failure of antibiotics by switching to another agent; when 
patients' general condition improved, intravenous antibiotics were changed to oral 
antibiotics. Since Haemophilus influenzae isolated from the respiratory tract was 
still susceptible to beta-lactams such as ampicillin and amoxicillin, cefuroxime was 
used excessively in treating community-acquired pneumonia in medical wards. 
When comparing local practice with recommendation of British and Australian 
experts, the study found high frequency of inappropriate use of antibiotic. It is 
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because there were differences in local disease patterns and antibiotic resistance 
patterns between Hong Kong, Britain and Australia. Data indicated that 51.5% of 
antibiotic courses were inappropriate with respect to indications and 30.2% of 
antibiotic courses were inappropriate with respect to choices of antibiotic, according 
to the standard of the reference guideline. The results did not infer that local 
practice was wrong or incorrect. Local practice could be different from the 
recommendations of Australian and British experts. Problems of antibiotic use in 
medical wards also contributed to inappropriate use. These problems were lack of 
national antibiotic guideline in Hong Kong, chest infection and sepsis being used 
loosely as diagnoses and incomplete documentation of clinical data in patients' case 
notes. This study highlighted the high frequency of inappropriate antibiotic use in 
hospital medical wards, a phenomenon which has been common in both developed 
and developing countries. The lack of systematic review or well conducted studies 
including randomized clinical trials may have contributed to this widespread 
phenomenon. In light of the development of new antimicrobial agents and 
emergence of resistant strains of microorganisms, there is a need to develop national 
or regional consensus statement or policy regarding the methodology of 
pharmacoepidemiology and conduct of well designed studies to promote the practice 
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This thesis reports an antibiotic audit undertaken at the medical wards of the Prince of 
Wales Hospital, a teaching hospital in Hong Kong. Data were collected from patients' 
case notes to examine the prescribing patterns of antibiotics, changes of antibiotic 
treatment and problems of antibiotic use. As national guideline was lacking in Hong 
Kong at the time of the study, an antibiotic reference guideline was developed based on 
the recommendations of the Australian antibiotic guidelines, the guidelines of the 
British Thoracic Society and the British National Formulary. Appropriateness of 
antibiotic therapies was measured based on the percentage of antibiotic therapies that 
adhered to the reference guideline. However, there are differences between Hong 
Kong, Britain and Australia in local disease patterns and antibiotic resistance patterns. 
Hence, when comparing local practice with recommendations of British and Australian 
experts, the study found high frequency of inappropriate use of antibiotics in Hong 
Kong. Despite these methodological limitations, the present study provided useful 
information for the development of hospital antibiotic guidelines. Firstly, the 
prescribing patterns of antibiotics for major infections, namely lower respiratory tract 
infection and sepsis were described. Secondly, sepsis was used loosely as diagnosis 
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when antibiotics were prescribed and incomplete documentation of clinical status were 
identified as important problems in the justification of use of antibiotics in medical 
wards. These problems also contributed to the high frequency of inappropriate 
antibiotic use. Development of national guidelines, periodic audit and education of 
doctors to improve clinical documentation are recommended at the end of this thesis. 
The World Health Organization (2000) described antimicrobial resistance as a 
global threat. As early as half a century ago, just a few years after penicillin was 
introduced in the market, scientists began to notice the emergence of a 
penicillin-resistant strain of Staphylococcus aureus. Resistant strains of gonorrhoea, 
dysentery-causing shigella and salmonella rapidly emerged after the first strain. The 
problem of antimicrobial resistance has accumulated to a serious public health concern 
since the first case of resistant staphylococcus. 
There was high resistance rate in Streptococcus pneumoniae and Haemophilus 
influenzae isolated from patients with community-acquired lower respiratory tract 
infections in Hong Kong, according to the Alexander project (Flemingham, Gninberg 
& the Alexander Project Group, 2000). The project monitored the susceptibility of the 
major lower respiratory tract bacterial pathogens to antimicrobials and to identify trends 
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in the development of resistance over time. Bacterial isolates were collected by local 
centres and were tested centrally in London. The project claimed that Hong Kong had 
a particularly high rate of beta-lactam-resistant Haemophilus influenzae in comparison 
with other centres in the study, namely London, Dublin, the Netherlands, Barcelona, 
Portugal, Switzerland, Czech Republic, Slovak Republic, Poland, the United States of 
America, Mexico city and so on (Flemingham et al., 2000). The project raised the 
concern that the rate of penicillin resistance of Streptococcus pneumoniae in Hong 
Kong was at least 50% (Flemingham et al., 2000) 
In Hong Kong, the Department of Health has started surveying antibiotic 
resistance in community setting since 1999 (Ma, Tsang & Kam, 2001). The antibiotic 
resistance patterns surveillance in 2000 made four important observations. Firstly, 
isolates of common urinary pathogens showed general increased quinolone resistance. 
Secondly, among Staphylococcus aureus isolates, a relatively high percentage (15%) 
was methicillin-resistant (MRSA). Thirdly, salmonellae showed marked increase in 
resistance to co-trimoxazole. And fourthly, as compared to the results of the Alexander 
project, 10% of Streptococcus pneumoniae isolates were penicillin-resistant and the 
author recommended that the occurrence of penicillin-resistant pneumococci should be 
monitored closely (Ma et al, 2001). Evidence from these sources showed that 
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resistance of micro-organisms to antibiotics in Hong Kong is an increasing problem. 
Infectious disease experts emphasized judicious use of antibiotics. Davey (1996) 
pointed out that failure of antimicrobial chemotherapy to control infectious diseases 
was not only due to the emergence of drug-resistant organisms, but also the 
inadequacies of infection control and the failure of individual prescribers to use 
antibiotics in the most effective manner. Additionally, Cohen (2000) attributed the 
emergence of methicillin-resistant staphylococci (MRSA), vancomycin-resistant 
enterococci (VRE) and multiple-drug resistant Gram negative bacilli to factors 
including the debilitated condition of patients, multiple courses of powerful antibiotics, 
long periods of hospital stay and inadequate practice for controlling infection. Prudent 
use of antibiotics therefore is regarded as an important factor in the control of antibiotic 
resistance. 
Having recognized the extensive and potentially inappropriate use of antibiotics, 
researchers have begun to survey antibiotic usage in hospitals since the 1970s. The 
United States, the United Kingdom, Australia and Canada started their surveys between 
1970s and 1980s, followed by Asian and African countries in late 1980s and 1990s. 
There are no standardized methods of assessing and comparing antibiotic 
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therapies. Hence, different countries were using different guidelines or standards 
to evaluate the appropriateness of usage of antibiotics and different results were 
yielded by different studies. Generally, the percentage of appropriate antibiotic 
therapies is higher in developed countries than in developing countries. About 65% to 
72% of therapeutic courses were appropriate in the USA (Maki & Schuna, 1978; 
Jogerst & Dippe, 1981; Scheckler & Bennett, 1970). In the UK, 81% of hospital 
therapeutic antibiotic prescriptions were appropriate in term of antibiotic choices (Moss, 
McNicol & McSwiggan et al, 1981a). In Australia, antibiotic treatments were 
appropriate between 52% and 72% (Harvey, Stewart & Hemming et al, 1983) but only 
21% of prophylactic courses adhered to an official guideline (Raymond, Robertson & 
Mashford, 1989). In Canada, 42% of surgical patients, 50% of gynaecological 
patients and 12% of medical patients were given irrational antibiotic treatments 
(Achong, Hauser & Krusky, 1977a). In Thailand, the problem of excessive use is 
serious. A study showed that the use of antibiotics were appropriate in only 27 out of 
307 patients in the medical wards of a university hospital (Aswapokee, Vaithayapichet 
& Heller, 1990). 
The Department of Health of Hong Kong stressed that total consumption of 
antibiotics and mode of antibiotic use were critical factors in selecting antimicrobial 
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resistance (Ma et al, 2001). Microbiologists in Hong Kong advocated hospital-wide 
cooperation to improve use of antimicrobials and to minimize over-prescription and 
inappropriate selection of agents (Ho & Wong, 2001). The situations of antibiotic use 
in Hong Kong remained unknown and the prescribing patterns of antibiotics in Hong 
Kong hospitals had not been systematically examined. 
The way that antibiotics were used to treat patients is another major concern. 
Previous studies on prescribing pattern of antibiotics in hospitals focused on the choice 
of antibiotics and their indications. Some of these studies also reported the 
appropriateness of the therapies according to pre-defined criteria. However, I found 
that these studies did not provide information on the consequences of treatment failure. 
In hospital wards, many antibiotics especially of intravenous antibiotics are often 
discontinued upon discharge and patients may be given a renewed course for 
completion at home. In the Prince of Wales Hospital, the regional hospital of Hong 
Kong New Territories east with a catchment population of one million, prescriptions 
orders are sent from wards to pharmacy every day. Pharmacists then dispense the 
required amount of drugs. At the same time, unused drugs including antibiotics are 
returned to pharmacy daily. My interest of antibiotic use in wards could be dated back 
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to a question why these antibiotics were unused. Evidence of antibiotics unused in 
wards can be found in an audit conducted in a medical ward of the Queen Mary hospital, 
another teaching hospital in Hong Kong (Kumana, Kou & Wong et al, 1993). The 
study calculated the cost of several expensive P-lactam antibiotics dispensed by 
pharmacy and the cost of these antibiotics administered to patients by nursing staff. 
The audit showed that the cost of antibiotics dispensed was greater than the cost of 
antibiotics given. According to the researchers, the second dose of a vial was 
sometimes unused and the wastage explained the cost difference. However, the audit 
did not explain why solid dosage forms such as tablets were unused in ward. The 
causes of interrupting antibiotic courses in wards are unclear. 
Against this background, I examined the prescribing pattern of antibiotics and the 
problems of antibiotic use in medical wards in the Prince of Wales Hospital in an 
attempt to understand how Hong Kong compares with other countries in this regard as 
well as to identify reasons why antibiotic wastage was common in these wards. 
Having assumed that antibiotic wastage was not connected with any one infection, I 
surveyed all antibiotic prescriptions as compared to selection of one particular 
infection. 
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At the time of the present study, national antibiotic guidelines was lacking in Hong 
Kong. However, antibiotic guidelines were available for reference in local settings, 
such as the Queen Mary hospital antibiotic guideline (Kumana, Chau & French, 1991) 
and the Impact guideline (Ho et al., 2001). There were a number of antibiotic 
guidelines written by international experts. The Australian antibiotic guidelines were 
authoritative guidelines written by experts in Australia and the guidelines were 
endorsed by Australian government and medical professional bodies in Australia. 
Experts in the British Thoracic Society also published their own guidelines regarding 
management of community-acquired pneumonia and chronic obstructive pulmonary 
disease. The British National Formulary (BNF) was another well-recognized 
reference for indications and dosing of drugs and was published by the British Medical 
Association and the Royal Pharmaceutical Society of Great Britain. Using 
international guidelines and the BNF as references and taking into account the 
hierarchy of evidence in developing guidelines (Shekelle, Woolf & Eccles et al., 1999) 
and patterns of infections and antibiotic resistance pattern reported by local 
microbiologists and the Department of Health, I prepared an antibiotic reference 
guideline to serve as the standard of antibiotic use with the help of my supervisor and 
medical colleagues. 
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In the present study, I reported the most frequently prescribed antibiotic, common 
sites of infection for which antibiotics were prescribed and the percentage of 
appropriate antibiotic courses in medical wards by comparing with the reference 
guideline developed for this audit purpose. I also examined the changes of antibiotic 
treatment in medical wards and reported the types and causes of such changes. I 
explained how these changes were relevant to our understanding of antibiotic use. 
The thesis is organized as follows. Chapter Two reviews the problem of 
antibiotic use in developed and developing countries. Chapter Three states the 
objectives of the antibiotic audit. Chapters Four and Five describe the methods and 
the results. Chapter Six discusses the problems of antibiotic use and concludes the 
inappropriate use of antibiotics in medical wards of the Prince of Wales Hospital. 
Chapter Seven summarizes the key findings of the study and Chapter Eight is my 
recommendations on how to reduce the unnecessary use of antibiotics and the need of 




Evidence from studies of antibiotic use in hospitals shows that misuse of antibiotics is a 
worldwide problem. In this literature review, I first summarized reports from local 
studies on antibiotic use and then briefly discussed the prescribing pattern of antibiotics 
in hospitals with respect to expenditure, indications, number of antibiotics prescribed 
and number of prescriptions issued. I also highlighted different aspects of antibiotic 
misuse with reference to 24 reports from developed and developing countries. At the 
end of this section, I explained the difficulties of surveying antibiotic use in hospitals 
and then concluded the problems of antibiotic use in hospitals. 
In Hong Kong, two drug utilization evaluations of antibiotics were reported. In 
an evaluation of antimicrobial treatment of community-acquired pneumonia, the 
prescribing pattern of empirical treatment of CAP in medical wards of the Prince of 
Wales hospital was described. During a three-month study period, 192 patients were 
evaluated. The empirical antimicrobial therapies of 52 patients (27%) complied with 
the Infectious Diseases Society of America (IDSA) guidelines (You, Lee & Au et al., 
2002). When utilization of vancomycin at the Prince of Wales hospital was evaluated, 
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a study found that 115 patients received 144 courses of vancomycin in a 11 -week 
evaluation period. A pharmacist and a consultant microbiologist evaluated the 
appropriateness of vancomycin use. The study found that according to the Center for 
Disease Control and Prevention (CDC) recommendations, 66 courses (46%) were 
appropriate and the remaining courses should have been discouraged (You, Lyon & Lee 
et a/., 2001). 
A decade ago, an audit of antibiotics was published in the Journal of the Hong 
Kong Medical Association (Kumana et al, 1993). The audit reported antibiotics being 
unused in a medical ward, which was described in the introduction of this thesis. The 
audit also reported the amount of liquid tetracycline sold per one thousand inhabitants 
per year from 1982 to 1991 in Hong Kong, with significant decline since 1983. The 
researchers explained that the decline was results of educational efforts and feedback to 
prescribers. The audit also found that intravenous instead of oral Unasyn® were given 
to patients who were able to swallow, did not have nausea, vomiting or malabsorption. 
To correct the excessive use of intravenous Unasyn®, medical officers were reminded 
to choose the well-absorbed oral antibiotic whenever feasible (Kumana et al, 1993). 
To find other reports of antibiotic use in hospitals, I performed a Medline search 
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using keywords such as “antibiotic audit", "antibiotic survey" and “antibiotic usage 
review" and selected 24 reports from developed and developing countries on patterns 
and problems of use of antibiotics. When interpreting results from these studies, two 
points deserved caution. First, for developed countries, data on assessment of 
antibiotic therapies came from studies conducted twenty to thirty years ago and more 
recent data were from developing countries. Second, these studies did not involve 
randomization of subjects nor comparison with controls. The findings in these studies 
were largely descriptive and do not result in our improved understanding of antibiotic 
use. For example, there were no randomized controlled trials studying the relationship 
between inappropriate use of antibiotics and emergence of resistant strains of 
micro-organisms. Despite the limitations, these early studies provided information on 
prescribing pattern of antibiotics and useful guidance on what aspects of inappropriate 
use of antibiotics should be looked for in hospitals. 
2.1 Prescribing patterns of antibiotics in hospital 
Literature showed that antibiotic was one of the most frequently prescribed classes of 
drug in hospitals. In developed countries, between 25% and 38% of hospitalized 
patients were given antibiotics. The percentages of patients receiving antibiotics in 
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developing countries were generally high ranging from 44% to 80%. Antibiotics 
constitute a substantial proportion of hospital drug expenditure particularly in 
developing countries. For example, available data show that antibiotic cost accounted 
for 39% of drug expenditures in a government hospital in Ghana, West Africa (Bosu & 
Ofori-Adjei, 1997). In Malawi, Central Africa, antibiotic cost contributed to 84% of 
drug expenditure in a central hospital (Harries, Willems, Pinxten et al, 1993). 
In developed countries, antibiotics were most frequently prescribed to treat lower 
respiratory tract infection, urinary tract infection, skin and soft tissue infection and 
septicaemia. In developing countries, in addition to the above infections, 
gastroenteritis was another popular indication (Harries et al, 1993; Tong, Pan, Chen et 
al, 1991; El-Teheawy, El-Bokl, El-Fattah et al, 1988).^ 
Antibiotic prescriptions given by practitioners in developed countries were simpler 
1 Eighty-two per cent of patients in the medical wards of the Malawi central hospital were given 
antibiotics. In this hospital, the main causes of admission to medical wards include malaria, 
tuberculosis, gastroenteritis, pneumonia, acquired immune deficiency syndrome (AIDS) and anaemia. 
AIDS patients were given antibiotics for the treatment of HlV-related infection (Harries et al., 1993). 
The growing AIDS epidemic in Africa means growing antibiotic demand and expenditure. 
2 Other indications for use of antibiotic in Ghana included diarrhoea, upper respiratory tract infection, 
viral infection and hepatitis (Bosu et al, 1997). In Thailand, antibiotics were prescribed for diseases 
including congestive heart failure, chronic airway obstruction and uraemia (Aswapokee et al., 1990). In 
Egypt, antibiotics were prescribed for prophylaxis in diseases including cerebrovascular accident, 
uraemia, chronic heart failure, and so on (El-Teheawy et al, 1988). In China, although antibiotics were 
prescribed for the treatment of infectious disease (44% of use of antibiotics) and for surgical prophylaxis 
(40%), antibiotics were also prescribed for non-infectious diseases (8%), non-surgical invasive procedure 
(2%) and even for unknown indications (5%) (Tong et al, 1991). 
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than those by practitioners in developing countries. In the USA, the UK and Australia, 
about two-third (60% to 87%) of antibiotic prescriptions consisted of only one 
antibiotic. In Malaysia and Ethiopia, most prescriptions consisted of two or more 
antibiotics. Only half of the antibiotic courses (48.5% in Malaysia and 55% in 
Ethiopia) were single-agent courses (Lim, Cheong & Suleiman, 1993; Aseffa, Desta & 
Tadesse, 1995). 
In developed countries, 80% of patients received two or fewer antibiotic 
prescriptions for one indication or during a single hospital stay (Kass, 1978; Jogerst et 
al, 1981; Griffiths, Bartzokas & Hampsom et al., 1986a). The percentage is lower in 
African countries. In Ethiopia, about 60% of patients were prescribed two or fewer 
antibiotic prescriptions (Aseffa et al., 1995). The situation was very different in 
Shanghai, China where two-fifth (40%) of patients were prescribed three or more 
antibiotic courses during a single hospital stay (long et al., 1991). Problems of 
prescribing multiple courses of antibiotics in China will be discussed in Section 2.2.3. 
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2.2 Worldwide problem of misuse of antibiotics 
Different problems of antibiotic use reported in literature are summarized in this section. 
These studies used different criteria of assessment and they identified different 
problems. Overall results of these studies showed that antibiotic therapies were 
appropriate in 34%-81% of cases. This review summarizes the major problems of 
antibiotic use in developed countries such as inappropriate indications, inappropriate 
choices of agents, inappropriate dosages, inappropriate routes of administration and 
inappropriate duration of therapies in Section 2.2.1. Reviews of the problems of 
prescribing antibiotics in Africa and in Asia are given in Sections 2.2.2 and 2.2.3. 
2.2.1 Misuse of antibiotics in developed countries 
Antibiotic usa^e reviews were conducted in the USA. the UK, Australia and Canada in 
the 1970s and 1980s. Although the percentages of appropriate antibiotic therapies 
were eenerallv high, there were major problems of antibiotic use in these countries. 
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2,2.1,1 The United States of America 
In the USA, between 65% and 72% of therapeutic courses were appropriate (Jogerst et 
al” 1970; Maki et al, 1978). The main problem in the therapeutic use of antibiotics 
related to indications. For instance, in a prospective eight-week survey conducted in a 
university hospital in Wisconsin, data were collected by a clinical pharmacist (Maki et 
al, 1978). The investigators classified indications of antibiotic courses as either 
presumptive infection or prophylaxis. Antibiotic therapies for presumed infections 
were appropriate when they fulfilled three criteria. Firstly, there were clinical signs 
and symptoms suggesting infections at the outset of therapies. Secondly, the choices 
of antibiotics were rational Thirdly, the therapies were modified as indicated by 
clinical course and results of bacteriological studies. Surgical prophylaxes were 
appropriate when they fulfilled four criteria for assessments. They referred to 
therapies which were used for potentially contaminated operations, commenced 
postoperatively, likely to be effective against anticipated microbial contaminants and 
were not continued beyond 72 hours postoperatively. The study reported that among 
149 antibiotic courses, 104 courses (70%) were for presumed infections and 65% of 
therapeutic courses were appropriate. The main problems were poor drug choice (22 
out of 37 inappropriate courses) and lack of clinical evidence of infections (13 courses). 
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The study also reported that doctors recorded in patient charts the start of antibiotic 
courses in only 34% of the cases and the reasons of prescribing antibiotics were 
provided in only 15% of the courses (Maki et al, 1978). Indications were unclear in 
these 34% of antibiotic courses. However, these conclusions should be interpreted 
with caution. The investigators explained that those antimicrobial therapies without 
clinical evidence of infection and without a statement in record specifying the suspected 
infection was considered prophylaxis. However, they did not explain whether the 
criteria for assessing the appropriateness of surgical prophylaxis were applied to these 
antibiotic courses. They also did not elaborate what was regarded as clinical evidence 
of infections despite one third of inappropriate therapeutic courses were categorized 
under this criteria. 
In another study conducted at a community hospital, therapies without indications 
recorded in patient charts were considered to be inappropriate (Jogerst et al, 1981). 
This was primarily an audit where the investigators were medical doctors who 
categorized the use of antibiotics as appropriate, probably appropriate and inappropriate. 
Antibiotic courses were appropriate when the investigators agreed with the use of 
antimicrobial therapy or prophylaxis. Probably appropriate uses were those situations 
in which potentially fatal or life-threatening bacterial infection could not be ruled out or 
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advantages derived from prophylaxis remained controversial. Antibiotic use were 
inappropriate when the investigators disagreed with the choices of antibiotics and 
recommended more effective, less toxic or less expensive ones; dosing or interval of 
administration were improper; duration of therapy was excessive; or there were no 
indications. The study reported that among 479 courses of antibiotics, two third were 
prescribed for therapeutic purposes and 72% of therapeutic courses were appropriate. 
Thirteen per cent of the therapeutic courses had no indications (Jogerst et al, 1981). 
The problem of prescribing antibiotics without proper indications in the United 
States was evident in a series of antibiotic usage studies conducted in seven community 
hospitals despite flaws in methodology of the study (Scheckler et al, 1970). The 
studies recorded evidence of infection documented by prescribers in charts when 
antibiotics were started. Fever alone, that is fever without other signs, symptoms or 
laboratory evidence of infection, was not considered to be an evidence for infection. 
The results showed that 62% of patients receiving antibiotic treatment had no definite 
evidence of any infection (Scheckler et al, 1970). This result should again be 
interpreted with caution. The investigators did not give example of laboratory 
evidence of infection. They also did not discuss the validity of definition of infection 
based on data from patients' chart. The investigators suggested that many of the 62% 
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of patients given antibiotics in the absence of clinical evidence of infection might be 
receiving some types of prophylactic therapy. The investigators also suggested that 
there were insufficient data in charts to allow proper assessment, and that antibiotics 
might have been given as a therapeutic trial even though criteria for definite evidence of 
infection were not met (Scheckler et al, 1970). In all these instances, the indications 
were unclear and possibly were inappropriate. Although the methodologies of these 
three surveys were subject to criticism, they all suggested that non-specific indications 
was the main problem of antibiotic use in the USA. 
2.2,1.2 The United Kingdom 
In the UK, studies showed that about one fifth of all antibiotic prescriptions were 
inappropriate regarding choices of agents and one third were considered to be 
unnecessary. In a one-month survey of antibiotic prescribing in a general hospital, 
prescribers were interviewed to determine the reason for each prescription (Moss et al, 
1981a). Therapeutic prescriptions were classified as appropriate or inappropriate with 
regard to the site of infection, the presumed/known infecting organisms and known 
antibiotic hypersensitivity. Prophylactic courses were considered appropriate if 
suitable intravenous antibiotic(s) were given before surgery and the intended duration 
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was not more than 24 hours. Among 437 courses of antibiotics, 71% were stated by 
prescribers to be therapeutic and 29% were prophylactic. The study reported that 81% 
(251 courses) of the therapeutic courses were appropriate treatment for the stated 
infection. In the remaining 19% of courses, the main problem was inappropriate 
choice of agent such as inadequate cover against the likely infecting organism or the 
stated infection. The study also reported that 30% (29 courses) of the prophylactic 
courses were used as non-surgical prophylaxis. Most of these courses were for trauma 
such as compound fracture and skull fracture. The investigators applied the criteria 
for assessing prophylactic course to all these courses and found that only 7% were 
appropriate (Moss et al, 1981a). In addition, in cases where the indications were not 
justified for the prophylactic use of antibiotics, the choices of agent and method and 
timing of administration were also mostly inappropriate. 
In another study, microbiologists disagreed with the practice of prescribing 
antibiotics without evidence of infection or in situations when usefulness of 
prophylaxes remained to be proven (Swindell, Reeves & Bullock et al, 1983). In a 
Bristol hospital, audits of antibiotic prescribing involved reviewing antibiotic 
prescriptions by microbiologists. The study were conducted in medical, surgical, 
orthopaedic, gynaecology, obstetric and urology wards and in accident and emergency 
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departments. A research registrar of the medical microbiology department visited 
wards daily to record antibiotic prescriptions and patients' clinical conditions. Two 
microbiologists then reviewed the data collected and assessed the appropriateness of 
antibiotic prescriptions with respect to indications, choices of agents, dosages, routes of 
administration and duration of treatments. Two audits were performed in the same 
wards and departments in two successive years involving 546 and 266 antibiotic 
prescriptions respectively. In these studies, both assessors (medical microbiologists) 
agreed that 28% and 35% prescriptions were unnecessary and choices of antibiotics 
were inappropriate in 17% and 16% respectively in these two audits (Swindell et al, 
1983). The study reported examples of inappropriate use. However, the number of 
prescriptions in each case was not reported. Antibiotic prescriptions were regarded as 
unnecessary in situations when patients were treated in the absence of clinical evidence 
of infection. Some examples were the use of antibiotics in vaguely unwell elderly 
patients and in patients who had nephrectomy when the use of prophylactic antibiotics 
remained to be proven. In the same study, when the organisms were known to be 
resistant to the antibiotics chosen or when penicillin was prescribed for patients with 
stated hypersensitivity, antibiotics were considered to be inappropriately selected 
(Swindell et al, 1983). 
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Other examples of inappropriate indications are found in a Liverpool teaching 
hospital (Griffiths et al., 1986a). Ward pharmacists identified antibiotic regimens 
prescribed for in-patients by reviewing prescription chart daily. A microbiologist then 
visited wards to collect patient details and clinical history. The study defined an 
antibiotic prescription or regimen as one or more antibiotics prescribed for a single 
indication irrespective of any subsequent change in dosage or route of administration. 
During the one-month study period, 246 prescriptions were issued for 
chemoprophylaxis. Although the study did not assess the appropriateness of antibiotic 
prescriptions, it reported 40 non-surgical chemoprophylaxes. Prophylactic courses of 
antibiotics were prescribed for multiple fracture, traumatic haematuria, urinary catheter 
insertion, Candida prophylaxis, skull fracture, and so on in order to prevent endocarditis 
or bacteraemia (Griffiths et al., 1986a). Usefulness of chemoprophylaxis to prevent 
infections in these situations remains to be proven. 
Above three studies conducted in the UK showed that some antibiotics were 
prescribed based on practitioners' subjective judgement of the disease despite the 
absence of evidence for infections. Based on these studies, over-prescription of 
antibiotics appears to be a problem in UK hospitals. 
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2,2,1,3 Australia 
Two hospitals in Australia reported similar problems of antibiotic use (Harvey et al, 
1983; Raymond et al, 1989). In three surveys of antibiotic use conducted in a 
teaching hospital, the Royal Melbourne Hospital, treatment which adhered to the 
antibiotic guidelines published by the Health Commission of Victoria was appropriate. 
In cases where antibiotics were prescribed for conditions not described in the guidelines, 
medical microbiologist or clinical pharmacologist was supposed to judge the 
appropriateness of the treatment. Inappropriate use was divided into four categories: 
lack of indication, wrong choice of an antibiotic, incorrect method of administration 
and inadequate cover. The four categories were not mutually exclusive. Some 
treatments were classified as inappropriate for more than one reason. The study 
reported that less than 15% of therapies were directed by positive microbiological 
findings. Three surveys have been conducted in the same hospital over a period of 
five years. It is interesting to note that the percentage of appropriate prescriptions 
increased from 50% to 70%. Among 255, 257 and 310 treatments evaluated in these 3 
surveys, 52%, 72% and 70% respectively were appropriate. Two problems of hospital 
antibiotic use persisted despite interventions such as distribution of official antibiotic 
guidelines and educational efforts. One problem was that 23% of surgical prophylaxis 
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were started 2 to 24 hours after surgery rather than before operation. The other 
problem was that intravenous ampicillin or amoxycillin were prescribed for pneumonia 
despite the fact that penicillin was recommended in the guidelines (Harvey et al, 1983). 
Similar findings were reported at the St. Vincent's hospital where ten antibiotic audits 
were conducted from 1976 to 1986 (Raymond et al, 1989). At the St. Vincent's 
hospital, appropriateness of antibiotic courses was determined with reference to the 
same official antibiotic guidelines as in the previous study (Harvey et al, 1983). In 
these ten antibiotic audits, between 109 and 223 courses had been surveyed, of these 
61% to 76% of treatment courses adhered to the official guidelines but only 21% of the 
prophylactic courses adhered to the guidelines. The main problem of non-adherence 
was that intravenous ampicillin alone or in combination with penicillin G was 
prescribed for empirical treatment of pneumonia when only penicillin G was 
recommended. Moreover, prophylactic antibiotics were started postoperatively rather 
than before operation (Raymond et al, 1989). These results showed that the use of 
antibiotic and the choices of agents often did not accord with the consensus of practice 
established at the time. The frequent use of antibiotics after surgery suggested that 
surgeons did not appreciate the need to use chemoprophylaxes perioperatively. Since 
there have not been follow-up studies, it remains unclear as to whether these problems 
have been solved or whether these inappropriate uses of antibiotics had any effect on 
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patient outcome or development of antibiotic resistant strains. These guidelines have 
been reviewed on every occasions following these antibiotic audits and have become 
authoritative statements in Victoria. In 1998, the tenth edition of the Antibiotic 
Guidelines established by the Health Commission of Victoria became applicable not 
only to Victoria but also other states and territories of Australia. The Australian 
Medical Association, the Health Department of Western Australia, the South Australian 
Health Commission and other official bodies all endorsed the publication. 
2,2,1,4 Canada 
In Canada, prophylactic use of antibiotics accounts for most cases of misuse (Achong, 
Hauser & Kmsky, 1977a; Achong, Wood & Theal et al, 1977b). A survey of 
antibiotic use conducted in medical，gynaecological and surgical wards of a Canadian 
teaching hospital reported the indications, prescribing patterns and percentages of 
rational therapies for four parenteral antibiotics, namely gentamicin, cloxacillin, 
ampicillin and cephalothin (Achong et al, 1977a). Clinical pharmacists collected data 
from patient's charts, and a clinical pharmacologist assessed each course of treatment. 
The treatment for a patient was considered rational when the choice of antibiotic and 
the dosage were appropriate for the infection or for the prophylactic purpose intended. 
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The treatment was questionable when clinical or microbiological data were insufficient 
to permit the therapy to be classified clearly as rational or irrational. Irrational 
treatments were divided into three types. Firstly, no antibiotics were indicated as there 
was no clinical or laboratory evidence of infection or when prophylactic antibiotic 
therapy was prescribed in cases of no proven efficacy. Secondly, the choice of 
antibiotic was inappropriate. Thirdly, the dosage was inappropriate such as 
prophylactic therapy given for more than five days or prophylactic oral antibiotic 
therapies given before or just after prophylactic parenteral therapies. Over a 
three-month period, at least one of the four antibiotics, gentamicin, cloxacillin, 
ampicillin and cephalothin, was given to 219 patients in three wards. Treatments were 
assessed as being irrational in 42%, 50% and 12% of surgical, gynaecological and 
medical patients respectively (Achong et al, 1977a). In gynaecological wards, among 
the 40 patients who received prophylactic therapies, 45% received oral antibiotics for a 
few days before the parenteral prophylactic therapies and 75% of the parenteral 
prophylactic therapies were replaced by oral antibiotic therapies. Similar approach of 
using both oral and intravenous antibiotics in prophylactic therapy was also reported in 
surgical ward (Achong et al, 1977a). As a result, the prophylactic courses were 
unnecessarily prolonged. In medical wards, the average duration of prophylactic 
parenteral therapies was 6.5 days. This number compared unfavorably to averages of 
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2.9 days and 5.6 days prophylactic courses given to gynaecological and surgical 
patients respectively (Achong et al., 1977a). The misuse of prophylactic antibiotics 
was a primary antibiotic use problem in the Canadian hospital. The duration of 
antibiotic courses, the dosages of antibiotics and routes of administration were 
inappropriate. In a follow-up survey in the same wards, changes in prescribing pattern 
took place and percentages of irrational treatment decreased (Achong et al, 1977b). 
Therapies were assessed as being irrational in 24%, 25% and 22% of surgical, 
gynaecological and medical patients respectively. The improvement was due to 
shorter duration of prophylactic therapies and the decrease in number of patients 
receiving oral antibiotics immediately before or after parenteral antibiotics (Achong et 
al.，1977b). 
2.2.2 Misuse of antibiotics in African countries 
Antibiotic usage reviews had been conducted in African countries including Ghana, 
Ethiopia, Malawi and Egypt. In Africa, although data regarding the percentage of 
appropriate antibiotic courses are not available, the problem of excessive use of 
antibiotics is obvious. 
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In Egypt, chloramphenicol was the second most frequently prescribed antibiotics 
in two government general hospitals and patients were given repeated courses of 
antibiotics (El-teheawy et al., 1988). Patient files were selected randomly from the 
two hospitals during the year of study. The study showed that antibiotics were given 
to 80.2% of patients. According to the authors, chloramphenicol was given to 23.1% 
of patients who received antibiotics, as compared to penicillins, which were most 
commonly used and were prescribed to 58.7% of patients (El-teheawy et al., 1988). 
Of the 1638 subject patients, 30.8% received repeated courses of antibiotics. The 
authors did not define single course and repeated course of antibiotics, it was unclear if 
renewed prescriptions were classified as repeated courses. The study classified the 
use of repeated courses. In 12.5% of 504 patients who received repeated courses, 
shortage and non-availability of the first drugs was the reason of changing antibiotics. 
No improvement, side effects, new indications and results of cultures were reasons of 
repeated courses in 9.1% to 0.4% of these patients. However, in 72.2% of these 
patients, the reasons of use of repeated courses were not apparent (El-teheawy et al., 
1988). Use of antibiotics without reasonable indications such as gastroenteritis and 
use of chemoprophylaxis in unjustified conditions such as cerebrovascular accident and 
uraemia were other problems in the Egyptian hospitals (El-teheawy et al., 1988). 
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In Ghana, although each patient received on average only 1.1 and 1.4 antibiotics 
from a teaching hospital and six government health care centres respectively, antibiotics 
were commonly prescribed for sore throat and common cold (Bosu et al., 1997). On 
the other hand, in Ethiopia, 5% of surgical patients were given five-antibiotic therapies 
and almost all patients were treated with antibiotics without bacteriological evidence of 
infection (Aseffa et al, 1995). The extensive use of chloramphenicol is also a 
problem in Ethiopia, Ghana and Malawi. Chloramphenicol was the second most 
commonly prescribed antibiotic in Ethiopia, preceded only by benzylpenicillin (Aseffa 
et al, 1995). Chloramphenicol constituted about 6% of antibiotics used in Ghana 
(Bosu et al, 1997) and one-third of total expenditure on antibiotics in Malawi (Harries 
et al, 1993). 
Based on these surveys, excessive use of antibiotics especially chloramphenicol 
appeared to be the main problem in African countries. This may be due to the very 
cheap cost and broad-spectrum activity of chloramphenicol. Use of repeated courses 
of antibiotics without apparent reason is another problem in Egypt. 
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2.2.3 Misuse of antibiotics in Asian countries 
Antibiotic audits had been conducted in Asian countries including Malaysia, China, 
Thailand and India. The percentage of appropriate antibiotic therapies was lower in 
Asian countries than in developed countries. In addition to the problems identified in 
developed countries such as treatment appropriateness, other problems were found, for 
example, the prescription of multiple courses of antibiotics in China. 
In Malaysia, the antibiotic prescribing patterns in six government general hospitals 
were surveyed (Lim et al, 1993). Data were collected by questionnaires completed by 
nursing staff or prescribers. The survey did not assess the appropriateness of 
prescriptions. A total of 1918 prescriptions from medical, surgical, paediatrics, and 
obstetrics and gynaecology departments were analysed. The prescriptions were issued 
for therapeutic purpose in 66% of cases and the remaining prescriptions were for 
prophylaxis. The mean duration were 6.54 days and 5.5 days for therapeutic and 
prophylactic prescriptions respectively. Non-surgical prophylaxis were intended to 
prevent pneumonia (36 prescriptions), neonatal sepsis (25 prescriptions) and 
septicaemia (15 prescriptions) (Lim et al, 1993). The pattern and reasons for the 
extensive use of prophylactic antibiotics required further examinations and analysis. 
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The usefulness of the above non-surgical prophylaxes was unproven and the duration of 
surgical prophylaxis would probably be too long based on the criteria of assessment 
used in developed countries. 
Prescribing multiple courses of antibiotics is a problem that has been identified 
amongst Chinese practitioners (long et al, 1991). According to long et al. (1991), in 
one year, 3596 antibiotic courses were prescribed for 1474 patients in a hospital in 
Shanghai. Of these patients, 40% were treated with three or more antibiotic courses 
during a single hospital stay. The auditors observed that multiple infections, frequent 
changes of antibiotic and unsuitable antibiotic combinations was the main reasons for 
the use of multiple courses. Treatment failure was probably another reason for 
practitioners to switch from one antibiotic treatment to another course despite lack of 
evidence to support such decision. The study did not assess whether these courses 
were appropriate or the clinical outcomes of patients who received the treatments. 
Nevertheless, the researchers concluded that the use of antibiotics was largely 
unnecessary in the hospital. Antibiotics were prescribed for non-infectious diseases 
(8% of total antibiotics used) or unknown indications (5%) in the hospital. Of the 295 
courses prescribed for non-infectious diseases, 35% were used for symptoms other than 
fever such as cough and headache, 30% for fever with no specific diagnosis, 20% for 
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peripheral leukocytosis and 15% for urinary leukocytosis (Tong et al, 1991). 
Findings from this study clearly show the problems that can arise from a wrong 
therapeutic decision in the first place which itself can lead to other inappropriate 
therapeutic decisions. 
Compared with China, the problems of antibiotic misuse were even more 
complicated in Thailand. In a cross-sectional study conducted in medical wards of a 
university hospital, among 307 patients surveyed, the use of antibiotics were considered 
to be appropriate only in 27 patients (Aswapokee et al, 1990). In this hospital, house 
staff decided empirical treatment of infections as soon as specimens were obtained for 
microbiological investigation without waiting for the results. "Treatment plans" were 
revised 72 hours after specimens were taken, when the microbiologic results returned. 
In this survey, the investigators adopted a different approach to assess the 
appropriateness of antibiotic courses. For patients whose diagnosis were revised after 
microbiological test results became available, the measurement of appropriateness of 
antibiotic use was performed twice for each treatment plan, first for the empirical use 
and then for the specific use. However, when microbiological test results did not alter 
the patient's initial diagnosis and the antibiotic therapy was not changed, the assessment 
was performed only once based on the initial prescription. The study did not explain 
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how many percent of patients had a microbiological report and did not explain the 
influence of microbiologic investigation on choice of antibiotics. The study showed 
that among 275 patients whose treatment plans were not revised, 110 patients were 
given antimicrobial agents without evidence of definite infection, 75 patients received 
inappropriate agents, and 48 patients received inappropriate doses, frequencies or 
duration of antibiotics. For the 32 patients who had revised treatment plan after 
availability of culture results, the choice of initial agents were inappropriate in 16 cases, 
and dosages, frequencies and duration of initial therapies were appropriate in only 2 
cases. When the revised therapies were assessed, indications were inappropriate in 8 
cases, choices of agent were inappropriate in 14 patients and dosages, frequencies and 
duration of antibiotics were inappropriate in 10 patients (Aswapokee et al, 1990). In 
this Thai hospital, the proportion of appropriate use was low even when 
microbiological reports were available. The majority of treatments were assessed as 
inappropriate either because the investigator could not find evidence of infections or 
because indications were inappropriate. Over-prescription of antibiotics thus is a 
problem in Thailand. 
In India, a study showed between 59% and 62% of antibiotic uses were 
appropriate (Thomas, Govil & Moses et al, 1996). Antibiotic use in 98 in-patients of 
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a primary care hospital and 87 in-patients of a tertiary care hospital was studied over 20 
weeks. The study classified the indications as either therapeutic or prophylactic and 
regarded prophylaxis as those therapies prescribed when there was no evidence of 
infection at the start of the antibiotic course. For therapeutic treatments, the main 
types of inappropriate use reported were insufficient duration of treatment, prolonged 
antibiotic courses and inadvertently starting or stopping antibiotics (Thomas et al, 
1996). However, the investigators did not clearly state their criteria of assessing 
antibiotic courses. Such parameters as appropriate duration of therapies were not 
defined, and the researchers did not explain clearly the meaning of therapies being 
inadvertently started or stopped. For prophylactic courses, in the primary care hospital, 
prophylaxis against wound infection was started postoperatively in 68% of the cases. 
In the tertiary care hospital, prophylaxis was always perioperative. Surgical 
prophylaxis was continued for more than seven days post-operatively in 33% of tertiary 
care hospital cases and in 50% of primary care centre cases (Thomas et al, 1996). 
The study also reported that 33% of incorrect empirical regimens were not changed to 
effective therapy even when the pathogen had been isolated and identified. According 
to the researchers, in some cases (numbers not reported), the ineffective antibiotics 
continued to be prescribed when the effective antibiotics were added (Thomas et al, 
1996). The treatments were likely to be irrational in these patients. However, 
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choices of agent were not among the reasons for inappropriateness in this study. 
Starting prophylactic therapies too late and prolonged prophylaxes were the two main 
areas of misuse. 
In these Asian countries, including Malaysia, China, Thailand and India, high 
proportion of therapies was assessed as inappropriate. Since criteria of assessment 
were unclear, identification of problems was relatively difficult. One obvious problem 
in China was prescription of multiple antibiotic courses. 
Few of the existing audit reports on antibiotic use from developed and developing 
countries discussed the validity of their assessment method. Methodologies and 
definitions also differ in different studies. For example, some studies regarded 
antibiotics prescribed without evidence of infections as non-surgical prophylaxis and 
some others regarded these as inappropriate treatments. Lack of common definition 
creates a barrier to compare the frequency of inappropriate antibiotic prescriptions on a 
common ground. Despite this variability, these studies showed that misuse of 
antibiotics is a worldwide problem. 
Concluding my appraisal of these literatures, five main problems of antibiotic 
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usage have been identified. They include inappropriate indications, inappropriate 
choices of agents, inappropriate dosages, inappropriate routes of administration and 




This study aims to examine the most frequently prescribed antibiotic in medical wards 
and the major sites of infection. With reference to the misuse of antibiotics in other 
countries, I also examined evidence on inappropriate use of antibiotics. I examined 
the changes of antibiotic treatment in medical wards. 
My investigation was undertaken as follows. I collected data from case notes 
from patients admitted to medical wards who were given antibiotics during the study 
period. Appropriateness of antibiotic therapies were assessed based on indications 
recorded in patients' case notes as well as choices, doses, routes of administration and 
duration of antibiotic therapies as recorded in the prescriptions. Appropriate 
indications and choices of agents were listed in my guideline and appropriate doses of 
antibiotics, routes of administration and duration of therapies were those that was safe 
and effective. Audit of patients' case notes is a relatively simple and useful method of 
examining antibiotic use, though more information on treatment decisions could be 
obtained by interviewing prescribers. It is hoped that antibiotic audit becomes a 
policy in hospitals and perhaps a routine duty in pharmacy practice; and that further 
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During a two-month study period from February 1998 to March 1998,1 went to 
nine medical wards (8A, 8B, 8D, 9A, 9B, 9C, 9D, IOC, lOD) at the Prince of Wales 
hospital every week from Monday to Saturday for about four hours each day. I 
identified patients who received antibiotic treatments by reviewing patients' case notes 
and data were collected using standard data collection forms. 
The Chief-of-Service of the Department of Medicine and Therapeutics was 
informed of the antibiotic usage review and endorsed the collection of patient and 
clinical information in medical wards. Figure 1 shows the processes of data 
collection. 
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Figure 1. Processes of data collection in an audit of use of antibiotics in a medical ward 
A patient visited A&E department and then was admitted to medical ward a . 
，r  
Doctor A assessed the patient, prescribed antibiotic X and recorded in patients' case notes. Patient was 
identified by the researcher and data were collected using a data collection form 
^ r  
Patient was observed by Doctor A in medical ward a and the 
researcher updated the data collection form when necessary. 
，r  
Doctor A off-duty, Doctor B took his place and 
recorded patient's progress in case notes. 
^r 
No — - — ^ - ^^   
Did the patient need surgery? 
i  
The patient consented to operation and was transferred to other departments (e.g. surgical ward). 
y_  
Surgery was finished and the patient was transferred to medical ward /3, and was taken care by Doctor 
C. Doctor C assessed the patient and recorded patient progress in the same case notes. 
The researcher reviewed case notes in medical ward jS, retrieved data collection 
form of the patient and updated it. 
•^丄 
Doctor D intended to discharge the patient in a few days' time and recorded in 
patients' case notes. The researcher completed data collection form. 
i  
Patient was discharged and the researcher recorded 
length of stay and clinical outcome of treatment. 
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4,2 Data 
The data collected for each patient were as follows. Since some of them required 
clarification, definitions will be given in Section 4.3. 
I. Patient name 
II. ID number 
III. Admission date 
IV. Sex and age 
V. Source of referral (for example, from emergency department) 
VL Patient location (ward and bed number) 
VII. Drug allergy 
VIII. Smoking habit 
IX. Drinking habit 
X. Regular medicine use 
XL Chronic disease and/or coexisting condition 
XII. Indication (for example, infection or surgical prophylaxis) 
XIII. Type of therapy (empirical, prophylactic or directed) 
XIV. Collection date and type of specimen sent for culture and susceptibility test 
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XV. Specific organism found as a significant pathogen and its susceptibility and 
resistance 
XVI. Antibiotic starting date 
XVII. Antibiotic(s) prescribed, route of administration, dose and frequency 
XVIII. Duration of antibiotic therapy 
XIX. Discharge date 
y 
XX. Destination to which patient was discharged (for example, rehabilitation 
facilities or home) 
XXL Clinical outcome of treatment (for example, discharged, discharged against 
medical advice, died of infection and died of reasons other than infection) 
XXIL Length of stay 
Any change to the antibiotic therapy given to a patient was recorded. The 
following data were collected to determine the cause of change: 
I. White cell count with or without differential count, and erythrocyte 
sedimentation rate (ESR) 
II. Serum creatinine concentration 
III. Percentage of arterial oxygen saturation (SaO:,)，pH, partial pressure of oxygen 
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and carbon dioxide in arterial blood 
IV. Presence of protein, red cell and white cells in urine 
V. Collection date and type of specimen sent for culture and susceptibility test 
VI. Specific organism found as a significant pathogen and its susceptibility and 
resistance 
VIL Doctors' interpretation of electrocardiography, chest radiography, abdominal 
radiography, endoscopy, tissue biopsy and examination results, and organ 
imaging results 
VIIL Other causes for change (for example, peer review during grand round) 
Patient data and clinical information were retrieved directly from patients' case 
notes. Section 4.3 defines the following terms: name of antibiotic, antibiotic course, 
antibiotic therapy, indications, types of antibiotic therapy, switch therapy, types of 
change, causes of change, clinical outcome of treatment and length of stay. 
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4,3 Definition of terms 
4.3.1 Name of antibiotic 
The generic names of antibiotics were used in the present study. For example, when 
Augmentin®, Unasyn® and 丁ienam® were prescribed, the present study adopted the 
generic names co-amoxiclav, ampicillin-sulbactam and imipenem-cilastatin 
respectively. 
4.3.2 Antibiotic course and antibiotic therapy 
There was no consensus on the definition of antibiotic course in the literature. In this 
study, an antibiotic course was an antibiotic treatment prescribed for one (or more) 
indication(s), usually the indications were infections or surgical prophylaxes. 
Antibiotics prescribed for short period of time such as one to two doses of surgical 
prophylaxis given in medical wards were also included. 
When antibiotic treatments were changed, they were divided into initial therapies 
and switch therapies. Usually antibiotics were prescribed and administered, and 
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patient progress was observed. Substantial number of prescriptions were revised after 
some days of observation. Some doctors added another agent to the initial 
prescriptions, some increased the antibiotic doses, some changed initial intravenous 
routes of administration to oral ones, and some interrupted the initial antibiotics and 
prescribed alternative antibiotics instead. 
Revision of treatments led to new prescriptions. Antibiotic courses were divided 
into initial therapies and switch therapies, so as to facilitate assessment of each 
prescription. Initial therapy was the first antibiotic prescription prescribed for a 
medical patient and switch therapy was the new prescription after change. Figure 2 
explains the method of classifying initial and switch therapies. 
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Figure 2. Example of change of antibiotic treatment in an audit of use of antibiotics in a 
medical ward 
A patient was admitted to medical 
ward, Doctor A prescribed IV 
X for the patient.  
y  
The patient stayed in medical wards for observation.  
Dosage change (first 
change) 
± ： ^ 乂 
The patient showed no responses to IV antibiotic X, Doctor 
n^reased the dose of antibiotic X by issuing new prescription. 
/ " ' s witch \ I 广 ； ^ 
i Antibiotic change 
Vtherapy J . . �^ ^ ^ ^ The patient did not respond to IV antibiotic (second change) 
X, Doctor A interrupted antibiotic X and ^ 
started IV antibiotic Y instead. 
i Antibiotic added (third 
The patient still did not show response I change) 
to IV antibiotic Y, Doctor A added IV ^ ^ 
antibiotic Z to the patient's regimen. 乂 
y  
The patient gradually improved after receiving IV 
antibiotics Y and Z, Doctor A observed the patient further. 
^ ^ 
IV to PO (fourth 
The patient was clinically stable, Doctor A change) 
changed IV antibiotics to PO antibiotics. > 
V  
Doctor A discharged the patient and prescribed discharge antibiotics. 
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4.3.3 Indications and types of antibiotic therapy 
This section explains initial therapy and the classification of antibiotic course. 
Treatments were of three types. An initial therapy was classified as empirical or 
prophylactic respectively when antibiotics were prescribed before microbiological test 
results were available. The indication referred to the infectious disease or the surgical 
procedure related to the prescribing of antibiotics respectively. When antibiotics were 
prescribed after pathogens had been isolated, or after confirmation of Helicobacter 
pylori infection by rapid urease test, the initial therapy was described as directed and 
the indication was the diagnosis, such as urinary tract infection and Helicobacter pylori 
eradication therapy. 
Sometimes the reasons of prescribing antibiotics were not found in patients' case 
notes. For example, the culture results were negative, no specific infections were 
recorded and the patients were not going to have surgeries. The indications were 
ascertained by careful review of case notes with clarification by my supervisor or 
medical colleague if necessary. The indications were the diagnosis at the time of 
prescribing of antibiotics as indicated by the prescribers in case notes, or patient signs 
and symptoms recorded for which antibiotics were prescribed. The therapies were 
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classified accordingly. However, therapies that were neither prescribed for proven or 
presumed infection nor for surgical chemoprophylaxis were not classified (hence 
unclassified). For example, pneumonia and chest infection were empirical therapies 
and viral hepatitis was unclassified therapy. 
Once the initial therapy has been classified as empirical, directed, prophylactic or 
unclassified, revision to the course should not modify the classification. Figure 3 
illustrates the method of classifying antibiotic courses. 
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Figure 3. Classification of antibiotic courses in an audit of use of antibiotics in a 
medical ward 
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4.3.4 Switch therapy 
The first switch therapy was the new prescription issued to revise an initial therapy. It 
might be followed by more subsequent changes resulting in second switch therapy and 
so on. I classified the types and causes of changes and examined the interaction 
between the two variables. 
4.3.5 Types of change 
The followings are different changes of antibiotic treatments when patients stayed in 
wards. 
L Change in route of administration referred to changes in the administration of 
the same antibiotics from intravenous to oral route (IV to PO), or vice versa (PO 
to IV). 
IL Dosage change referred to the change in the amount of antibiotics given in a 
dose and/or the frequency of administration of the antibiotics, 
in. Antibiotic added referred to the addition of new antibiotic(s) to an initial or 
switch therapy. 
IV. Antibiotic change referred to the discontinuation of any one antibiotic from an 
50 
initial or switch therapy with or without starting another antibiotic, so that new 
antibiotics or a new combination of antibiotics were used in the treatment. 
4.3.6 Causes of change 
The causes of change were classified as follows: 
I. Clinical evidence of improvement, for example, lowered temperature, decreased 
white cell count and improvement in symptom such as decreased shortness of 
breath (Symptom improved) 
II. No clinical evidence of benefit (Not responded) 
III. Susceptibility test results suggesting alternative treatment (Susceptibility test 
result) 
IV. Peer review/discussion in grand round suggesting alternative treatment (Grand 
round) 
To summarize, any changes to an antibiotic treatment were recorded and the new 
prescriptions were classified as the first switch therapy, the second switch therapy and 
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so on. The types and causes of change were classified. Figure 4 illustrates the 
classification of switch therapy. 
Figure 4. Classification of types of change and causes of change of antibiotic treatments 
in an audit of use of antibiotics in a medical ward 
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4.3.7 Clinical outcome of treatment 
Table 1.1 shows the classification of the clinical outcome of treatment. Patient 
outcome as recorded in case notes such as discharged, discharged against medical 
advice and died were collected. Outcomes such as cure rate and complications which 
required follow-up assessment were not included in the present study. Patient 
antibiotic discontinuation date, discharge date and health care facility to which a patient 
was transferred were recorded for evaluation of clinical outcome, and for calculation of 
length of acute hospital stay. 
Table 1.1 Classification of clinical outcome of treatment in an audit of use of antibiotics 
in a medical ward 
Clinical outcome of treatment Patient outcome that fulfill the classification 
Discharged Patient was discharged home or was transferred to 
other health care facilities 
DAMA Patient discharged himself gainst medical advice, 
without approval of doctor-in-charge 
Died of infection Patient died in medical ward because of infection 
Died of causes other than Patient died in medical ward due to underlying or 
infectious disease other acquired disease(s) during hospitalization 
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4.3.8 Length of stay 
Length of stay was the period of time a patient stayed in the acute medical wards at the 
Prince of Wales hospital. It was calculated by counting the number of days of hospital 
stay. For a patient who was admitted on March 1998 and was discharged or was 
transferred to other hospital on 21'^  March 1998, the length of stay was two days. For 
a patient who was discharged on the same day when he or she was admitted, the length 
of stay was one day. 
4,4 Determination of pattern of use 
The present study analyzed the pattern of use of antibiotics, with respect to types of 
therapy (empirical, directed, prophylactic and unclassified), indications, the most 
frequently prescribed antibiotics, number of antibiotics prescribed in a prescription and 
number of prescriptions prescribed in an antibiotic course. The pattern of use in 
switch therapy demonstrated a relationship between the types and causes of change in 
antibiotic treatments. 
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4,5 Assessment of antibiotic therapies 
Appropriateness of antibiotic therapies was assessed as the percentage of antibiotic 
courses that adhered to a guideline developed by me, with help from my supervisor and 
medical colleague based on evidence from current literature and published guidelines 
such as the Australian antibiotic guidelines that were widely accepted authoritative 
guidelines in Australia. The main features of my guideline are given in Section 4.6. 
I did not assess the quality of clinical diagnoses and the quality of pathogen 
isolation in specimens. Instead, I concentrated on the appropriateness of antibiotic 
prescriptions based on doctors' diagnosis of infection. Diagnosis was an objective 
evidence for determining the appropriateness of antibiotic use. 
Appropriateness cannot be measured only by the clinical outcome of treatment. 
Clinical outcome of treatment is the result of collaborative effort of workers in the 
health care system. Improving the clinical outcome of treatment is the ultimate goal 
of evaluating therapy and also the ultimate goal of therapy. However, the processes of 
patient care including physical assessment, investigation and diagnosis would also 
contribute to outcome of antibiotic treatment. Other factors including effects of drug 
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and non-drug treatment, activities of other paramedical professionals, and patient 
factors such as underlying diseases should also be taken in account. 
I did not neglect the contributing role of other health care workers in patient care. 
However, in the present study, I focused on the use of antibiotics by prescribers, whose 
professional standard of patient care is reflected by the quality of prescribing. In short, 
the quality of prescribing reflects the appropriateness of the use, and the 
appropriateness of use in return measures the quality of prescribing. Prescribing and 
not prescribing of a therapy demonstrates the practitioners' knowledge of appropriate 
use. However, I have not measured the proportion of treatment withheld before the 
therapy was prescribed. 
I defined appropriate antibiotic therapies as those which have appropriate 
indications, choices of agent, dosages, routes of administration and duration of 
therapies. Achong et al (1977a) defined irrational antibiotic treatment as follows. 
Firstly, the antibiotics were prescribed in the absence of clinical and laboratory 
evidence of infection. Secondly, the prescribing of prophylactic therapy which had no 
proven effect on the prevention of post-operative infection. Thirdly, the choice of 
antibiotic was inappropriate when the isolated pathogen was not susceptible to the 
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antibiotic. Fourthly, the duration of a prophylactic or indicated therapy was too long 
or the dose of antibiotic was too large for renally impaired or paediatric patients. 
Parish (1973) described rational prescribing as drug use which was appropriate, 
effective, safe and economical. An antibiotic course was appropriate in the present 
study if it was safe and effective (appropriate dose, route of administration and duration 
of therapy) and if it was rational and economical (appropriate indication and choice of 
agent as listed in the antibiotic reference guideline). 
As changes of treatment were examined and antibiotic courses were divided into 
initial and switch therapies, I considered an antibiotic course to be appropriate when 
both the initial and the switch therapies were appropriate. The determination of 
appropriateness of initial therapy was based on the five criteria of assessment: the 
indications, choices of agent, dosages, routes of administration, and duration of 
therapies. When all the above parameters were appropriate, an initial therapy was 
appropriate. For switch therapies, when routes of administration, dosages and 
duration of therapies were appropriate, the switch therapies were appropriate. The 
details of criteria of assessment are given in Sections 4.5.1 to 4.5.4. Figure 5 
summarizes how appropriateness of antibiotic therapies was determined. 
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Figure 5. Determination of appropriateness of antibiotic therapies in an audit of use of 
antibiotics in a medical ward 
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4.5.1 Assessment of indication and choice of agent 
Appropriate indications and choices of agent were listed in the antibiotic guideline in 
Section 4.6. For empirical and prophylactic therapies, indications and choices of 
agent that adhered to guideline were assessed as appropriate. For directed and 
unclassified therapies, the indications and choices of agent were assessed individually. 
Choices of agents were examined with reference to susceptibility test results in case of 
directed therapies. For Helicobacter pylori eradication therapy, the appropriate 
regimens were given in the antibiotic guideline. A few points need clarifications. 
Since my guideline applied to empirical treatment and surgical chemoprophylaxis only 
and it did not apply to switch therapies, the guideline was compared with initial 
therapies only. Similarly, directed and unclassified therapies were not compared with 
the guideline. When antibiotics were prescribed for infections or for proven surgical 
chemoprophylaxis, the indications of these therapies were appropriate. When 
antibiotics were prescribed for non-infections or for infections not due to bacterial 
causes, they were unnecessary. I considered unnecessary uses as inappropriate 
indications. For example, Helicobacter pylori eradication therapy was appropriate 
indications. However, chest infection not supported by clinical signs and symptoms or 
microbiological evidence, and viral hepatitis were inappropriate indications. To avoid 
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confusion, appropriate indications were listed in my antibiotic guideline. 
In all cases, choices of agent were considered inappropriate when antibiotics were 
prescribed for patients with known hypersensitivity and when antibiotics were 
continued despite isolation of resistant micro-organisms. 
4.5.2 Assessment of dosage 
The dosage of antibiotics was appropriate when it was within safety range. For 
example, the dosage of ceftazidime should be adjusted for patients who had renal 
impairment. Table 1 1 shows appropriate dosages of ceftazidime. 
60 
Table 1.2 Recommended maintenance dosages of ceftazidime in renal insufficiency 
(Adapted from Physicians' Desk Reference Generics, ed. 1997. Montvale, NJ : 
Medical Economics and Cockcroft & Gault, 1976) 
Creatinine clearance in Recommended unit dose of Recommended frequency of 
ml/min ceftazidime dosing 
50-31 Ig ql2h 
30-16 Ig q24h 
15-6 500mg q24h 
<5 500mg q48h 
When only serum creatinine was available, the following formula (Cockcroft’ s equation) 
might be used to estimate creatiine clearance. The serum creatinine should represent a 
steady state of renal function. 
Creatinine clearance in ml/min for male = 
(140-age) X (body weight in kg) 
(serum creatinine concentration in mg/100ml) x 72 
Creatinine clearance for female 二 male value x 0.85 
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4.5.3 Assessment of route of administration 
Appropriate route of administration was a safe and effective route that delivered 
antibiotics to the anatomical site of infection. For example, oral route was an 
appropriate route to deliver quinolones to patients who could ingest solid food and who 
were not vomiting. 
4.5.4 Assessment of duration of therapy 
Duration of therapies was inappropriate when antibiotics were continued despite 
adverse drug reaction or drug interaction involving the antibiotics, and when antibiotics 
was continued even after isolation of resistant pathogen. Otherwise, the duration of 
therapy was appropriate. 
To summarize, an initial therapy was assessed with reference to indication, 
choice of agent, dose, route of administration and duration of therapy and a switch 
therapy was assessed with reference to dose, route of administration and duration 
of therapy. When initial and switch therapies of an antibiotic course were 
appropriate, the antibiotic course was appropriate. 
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4.6 Features of the guideline developed for the present study 
A new set of antibiotic guideline was prepared for the present study and was shown on 
the next page. Based on the recommendation of the Australian antibiotic guidelines, 
the guidelines of the British Thoracic Society and the British National Formulary, 
appropriate agents for different indications were given in the antibiotic reference 
guideline. 
Data concerning long-term effect such as teratotoxicity of new agents is at the 
moment inadequate. Moreover, antibiotic use selected bacterial resistance. Prudent 
use of existing agent is stressed and new agents are reserved for unresponsive infections. 
Therefore, the guideline adopted as many old antibiotics as appropriate agents as 
possible. The preferred antibiotic in a class were given in the antibiotic reference 
guideline. For example, when macrolide was the appropriate choice and erythromycin 
was preferred, erythromycin was given in the guideline. When two antibiotics in a 
class were appropriate for an indication, both were given in the guideline, such as 
co-amoxiclav and ampicillin-sulbactam, and cefotaxime and ceftriaxone. In this case, 
the first antibiotic appeared in the guideline was preferred to the second antibiotic. 
When three or more regimens were appropriate, the preferred regimen was listed first in 
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the guideline, followed by the alternative regimens. More features of the guideline are 
explained in Sections 4.6.1 to 4.6.3. 
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Table 1.3 Antibiotic guideline for the empirical treatment of infection and for surgical 
chemoprophylaxis in an audit of use of antibiotics in a medical ward 
(Adapted from Writing group for therapeutic guidelines: antibiotic, 1998; The COPD 
Guidelines Group of the Standards of Care Committee of the BTS, 1997; Pneumonia 
Sub-committee of the Research Committee of the British Thoracic Society, 1993 and 
British National Formulary, 2000) 
EAR, NOSE AND THROAT INFECTION 
Acute otitis media or acute sinusitis 
PO amoxycillin 500mg tds 
Or PO trimethoprim 200mg bd 
If not respond 
PO co-amoxiclav 750mg tds 
Or PO ampicillin-sulbactam 750mg bd 
LOWER RESPIRATORY TRACT INFECTION 
Community-acquired pneumonia 
In previously healthy patient 
PO amoxycillin 250-500mg tds 
Or PO co-amoxiclav 375mg tds 
Or PO ampicillin-sulbactam 750mg bd 
for mild case 
IV Penicillin 2MU q6h + IV erythromycin 500mg-lg q6h 
for moderate to severe case 
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In suspected ‘atypical’ pneumonia or penicillin-allergic patient 
PO erythromycin 500mg qid 
In life-threatening pneumonia of undetermined aetiology in previously healthy patients. 
IV erythromycin 500mg to Ig q6h + 
IV ceftriaxone Ig q24h 
Or IV erythromycin 500mg to Ig q6h + 
IV cefotaxime Ig q8h 
Hospital-acquired pneumonia 
IV ceftriaxone lgq24h 
Or IV cefotaxime Ig q8h 
Aspiration pneumonia 
IV penicillin 2MU q6h 
Or IV clindamycin 600mg q8h 
If not respond 
IV penicillin 2MU q6h + PO metronidazole 400mg tds 
Or IV penicillin 2MU q6h + IV metronidazole SOOmg q8h 
If Gram negative bacilli suspected 
IV ceftriaxone Ig q24h + IV metronidazole SOOmg q8h 
Or IV cefotaxime Ig q8h + IV metronidazole 500mg q8h 
Infective exacerbation of chronic bronchitis 
PO amoxycillin 250-500mg tds 
If not respond 
PO co-amoxiclav 375mg tds 
Or PO ampicillin-sulbactam750mg bd 
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If penicillin allergic 
PO erythromycin 500mg qid 
BRONCHIECTASIS 
If during infective exacerbation 
PO ofloxacin 400mg bd for mild case 
IV ceftazidime l-2g q8h for moderate to severe case 
TUBERCULOSIS 
If no prior TB {viz. new case) 
In patient aged under 40 and shows no evidence of renal impairment 
PO isoniazid 15mg/kg + PO rifampicin 600mg + PO pyrazinamide 2.5g + 
IM streptomycin 1 g 
three times per week for 2 months, followed by 
PO isoniazid 15mg/kg + PO rifampicin 600mg 
three times per week for 4 months 
In patient aged above 40 or renally impaired 
PO isoniazid 15mg/kg + PO rifampicin 600mg + PO pyrazinamide 2.5g + 
PO ethambutol 1.2g(15 to 25 mg/kg) 
three times per week for 2 months, followed by 
PO isoniazid 15mg/kg + PO rifampicin 600mg 
three times per week for 4 months 
Please note that ethambutol is not recommended for children 
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If recurrent TB and resistance of mycobacteria unknown 
PO isoniazid 15mg/kg + PO rifampicin 600mg + PO pyrazinamide 2.5g + 
PO ethambutol 1.2g(15 to 25 mg/kg) 
daily for 2 months, followed by 
PO isoniazid 15mg/kg + PO rifampicin 600mg 
for 4 months 
Please note that ethambutol is not recommended for children 
URINARY TRACT INFECTION 
Acute cystitis 
PO trimethoprim 200mg bd 
Or PO co-amoxiclav 375mg tds 
Or PO ampicillin-sulbactam 750mg bd 
Pyelonephritis 
PO trimethoprim 200mg bd 
Or PO co-amoxiclav 375mg tds 
Or PO ampicillin-sulbactam 750mg bd 
If not respond or if Pseudomonas aeruginosa is suspected 
PO norfloxacin 400mg bd 
If feverish 
IV ampicillin 2g q6h + IV gentamicin 7.5mg/kg/day 
Or IV ceftriaxone l-2g q24h 
Or IV cefotaxime l-2g q8h 
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PROSTATE INFECTION 
PO erythromycin SOOmg qid 
Or PO tetracycline SOOmg qid 
Or PO ofloxacin 400mg bd 
SEPTICAEMIA / SEPSIS 
If infecting organism unknown 
In normal adult 
IV gentamicin 5-7mg/kg/day + IV cloxacillin 2g q6h 
In neutropenic patient 
IV ceftazidime Ig q8h 
Or IV ceftazidime lgq8h + IV gentamicin 5-7mg/kg/day 
If MRSA is suspected 
IV vancomycin 500mg-lg ql2h 
SKIN AND SOFT TISSUE INFECTION 
Cellulitis 
PO/IV cloxacillin 500mg qid/q6h 
If Gram-negative organism is suspected 
PO/IV co-amoxiclav 750mg tds/qSh 
Or IV gentamicin 7.5mg/kg/day 
Gangrene (necrotising cellulitis) 
IV penicillin 4MU q4h + IV gentamicin 5-7mg/kg/day + 
IV metronidazole SOOmg q8h 
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GASTROINTESTINAL TRACT INFECTION 
Acute cholangitis 
IV ampicillin 2g q6h + IV cefuroxime 750mg q8h 
Please note that IV metronidazole 500mg ql2h is added after isolation of 
anaerobe in blood 
Helicobacter pylori eradication therapy 
PO Clarithromycin 500mg bd + PO Amoxycillin 1 g bd 
plus Ranitidine bismuth citrate Or proton-pump inhibitor 
Or PO Clarithromycin 500mg bd + PO metronidazole 400mg bd 
plus Ranitidine bismuth citrate Or proton-pump inhibitor 
Or PO Amoxycillin 500mg tds + PO Metronidazole 400mg tds 
plus proton-pump inhibitor 
CENTRAL NERVOUS SYSTEM INFECTION 
Meningitis 
If infecting organism unknown 
IV ceftriaxone 2g ql2h + IV penicillin 3MU q4h 
Or lY cefotaxime 2g q6h + IV penicillin 3MU q4h 
Brain abscess 
IV ceftriaxone 2g ql2h + IV penicillin 3MU q4h + IV metronidazole 500mg q8h 
Or IV cefotaxime 2g q6h + IV penicillin 3MU q4h + IV metronidazole 500mg q8h 
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ENDOCARDITIS 
If infecting organism unknown 
IV penicillin 3MU q4h + IV cloxacillin 2g q4h + IV gentamicin 2mg/kg q8h 
SURGICAL CHEMOPROPHYLAXIS 
Pacemaker implantation/generator change 
IV cefazolin Ig at the time of induction 
�e n d of guideline � 
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4.6.1 Ceftriaxone and cefotaxime are appropriate for treating serious infections 
Ceftriaxone is a first line agent in gonococcal infection, since penicillin-resistant strains 
of Neisseria gonorrhoeae are frequently involved (Writing group for therapeutic 
guidelines: antibiotics, 1998). However, ceftriaxone should not be prescribed only for 
gonorrhoea. Ceftriaxone has similar spectrum of bacteriological action as cefotaxime, 
but has an advantage that it allows once daily dosing schedule as compared to three 
times daily dosing schedule of cefotaxime. In my guideline, both ceftriaxone and 
cefotaxime are first line agents in treating serious infections. Ceftazidime is an 
appropriate agent in treating septicaemia in neutropenic patients because of its 
anti-pseudomonal activity. 
4.6.2 Cefuroxime is not a first line agent 
With the exception of treating acute cholangitis, cefuroxime is not a first line agent in 
my guideline. Co-amoxiclav and gentamicin are recommended if Gram-negative 
organism is suspected and third-generation cephalosporins are recommended for severe 
infections such as meningitis. Cefuroxime is active against Streptococcus pneumoniae 
and Haemophilus influenzae and was reported to be effective in treating pneumonia 
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(Rodjer, Alestig & Bergmark et al, 1996; Higuera, Hidalgo & Feris et al, 1996). 
However, there is no conclusive evidence to support replacing traditional antibiotics 
such as amoxycillin and erythromycin by cefuroxime as a first line agent in treating 
pneumonia. Following most international guidelines, my guideline put much 
emphasis on using old but effective antibiotics. 
4.6.3 Regimen for Helicobacter pylori eradication 
The British Medical Association and the Royal Pharmaceutical Society of Great Britain 
recommend using antibiotics plus a proton-pump inhibitor or plus ranitidine bismuth 
citrate to eradicate Helicobacter pylori (BNF, 2000). I used the same regimen in my 
guideline. 
4 J Statistical analysis 
Percentages, mean values with standard deviation (SD) were presented. Statistical 
analyses were preformed using the Microsoft Excel 97. Number of changes of 
treatment, different types of change and different causes of change were collected by 




This chapter shows results obtained from patients' case notes. Section 5.1 shows 
patient demographic data and length of stay. Section 5.2 shows the patterns of use. 
Section 5.3 shows the results of assessment and Section 5.4 shows the clinical 
outcomes of treatment. 
5.7 Antibiotic courses and patients 
5.1.1 Inclusion and exclusion of antibiotic courses 
Three hundred and twenty-four antibiotic courses were available for analysis. During 
a two-month study period, I identified 620 antibiotic courses in medical wards. In 162 
(26.1%) cases, although the prescription of antibiotics was recorded, clinical 
information such as indications and patient demographic data were not available and 
therefore the appropriateness of use cannot be evaluated. In another 124 (20.0%) 
courses, the dates on which patients were discharged or transferred were not available. 
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In the remaining 334 courses, indications were not available in ten cases. 
Therefore, 324 antibiotic courses were evaluated. Figure 6 shows the inclusion and 
exclusion of antibiotic courses. 
Figure 6. Inclusion and exclusion of antibiotic courses in an audit of 
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5.1.2 Patient sex and age 
Three hundred and eighteen patients entered the present study. Six patients were 
admitted to the medical wards twice within the study period and one course of 
antibiotics was given in each admission. One hundred and sixty-two (50.9%) patients 
were male. Patient age ranged from 15 to 101 years. The mean age of male patients 
was 69.1 土 14.0 years and the mean age of female patients was 74.3土 16.2 years. 
5.1.3 Chronic disease/past medical history 
Figure 7 shows the chronic diseases and past medical history of patients. The average 
number of chronic disease per patient was 1.4. Among different chronic diseases, 
25.3% were chronic lung diseases including chronic obstructive airway (pulmonary) 
disease (COAD/COPD), bronchiectasis and asthma. Circulatory disorders and cardiac 
diseases including hypertension, ischaemic heart disease, cerebrovascular accident, 
congestive heart failure, atrial fibrillation and cor pulmonale made up 40.6% of chronic 
diseases. Diabetes mellitus accounted for 13.5% of chronic diseases. Renal failure 
and benign prostatic hypertrophy each accounted for 1.6% of chronic diseases. 
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Figure 7. Chronic diseases or past medical histories of patients in a medical 
ward 
f\ — —   
90   
gQ 丨、18• 1 17]oj^^ ----- - —__— 
p  
70 — L;  
窝 . n —" — (1-巡 
1 � . : ；V rq 
§ 50 � - J - 
S _ : (9.5%) 
^ 40 - •‘ ： - _ 2 7 " 
1 ？ > ，: 5 24 
I 30 . " V r n � -n吐(5：6%厂!^- .-1-5 
^ 20 ‘ ：： . 7 ； ； - 口 厂 卜 卜 1 - - - 7“―厂 - 7 6 -
JJ I M i l i LI H LQLI E i 口 
# / z 
Chronic diseases/past medical histories 
77 
5.1.4 Length of stay 
The length of stay of patients ranged from one day to 78 days and the mean was 
9.4+7.9 days. Figure 8 shows the distribution of length of stay. 
Figure 8. Length of stay of patients in a medical ward 
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5.2 Pattern of use 
5.2.1 Indications and sites of infection 
Two hundred and ninety-four (90.7%) patients received antibiotic treatment due to one 
indication, twenty-nine (9.0%) due to two indications and one (0.3%) due to three 
indications (sepsis, tuberculosis and urinary tract infection). In total, 355 indications 
were recorded. These indications were classified into 54 categories. Lower 
respiratory tract was the most frequent site of infection (58.6%), the indications 
included chest infection, pneumonia, aspiration pneumonia and chronic obstructive 
airway disease or infective exacerbation of chronic obstructive airway disease as 
recorded by the doctors. Sepsis accounted for 8.2% of infection. The third 
commonest site of infection was the urinary tract (5.1%). Table 2.1 shows different 
indications of antibiotics and their prevalence in medical wards. These indications 
were appropriate if they concorded with the guideline of the present study. Different 
inappropriate indications are also presented in the same table (Nos. 1, 14 to 31 and 37 
to 54). 
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Table 2.1 Appropriate and inappropriate indications of antibiotic usage in 355 treatment 
courses in patients in a medical ward. The inappropriate indications are highlighted in 
bold. 
Indication as recorded in case notes Appropriate frequency Percentage 
indication? (%) 
1 Chest infection No 127 35.8 
2 Pneumonia Yes 17 4.8 
3 Aspiration pneumonia Yes 5 1.4 
4 COAD or Infective exacerbation of Yes 59 16.6 
COAD 
5 Sepsis Yes 29 8.2 
5 UTI Yes 19 5.1 
7 Prostatitis Yes 1 0.3 
g TB Yes 8 2.3 
9 Cellulitis Yes 3 0.8 
10 Gangrene Yes 1 0.3 
11 Bronchiectasis Yes 12 3.4 
12 Otitis media Yes 1 0.3 
13 URTI Yes 1 0.3 
14 Acute pulmonary oedema No 3 1.1 
15 Hyperinflated lung upon chest x-ray No 2 0.6 
16 Lung cancer No 3 0.8 
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Table 2.1 continued 
Indication as recorded in case notes Appropriate frequency Percentage 
indication? (%) 
17 Haemoptysis No 3 0.8 
18 Pneumothorax No 3 0.8 
19 Asthma No 3 0.8 
20 Bulla disease No 2 0.6 
21 Unproductive cough No 1 0.3 
22 Emphysema No 1 0.3 
23 Pleural effusion No 2 0.6 
24 Skin rash No 1 0.3 
25 Facial erythema No 1 0.3 
26 Pemphigoid No 1 0.3 
27 Dermatitis/atopic eczema No 2 0.6 
28 Phlebitis No 1 0.3 
29 Viral infection No 1 0.3 
30 Obstructive jaundice No 1 0.3 
31 Viral hepatitis No 1 03 
32 Acute cholangitis Yes 3 0.8 
33 CNS infection Yes 2 0.6 
34 Pacemaker implantation/generator Yes 2 0.6 
change 
35 Helicobacter pylori eradication therapy Yes 9 2.5 
36 Subacute bacterial endocarditis Yes 1 0.3 
37 Ascites ^ | 0.3 
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Table 2.1 continued 
Indication as recorded in case notes Appropriate frequency Percentage 
indication? (%) 
38 Cerebrovascular accident No 2 0.6 
39 Hypothermia No 1 0.3 
40 Hyperglycaemia No 1 0.3 
41 Diabetic ketoacidosis No 1 0.3 
42 Osteoarthritis of knee No 1 0.3 
43 Knee pain No 1 0.3 
44 Wound pain No 2 0.6 
45 Chill and rigor after operation No 1 0.3 
46 Heart failure with fluid retention No 1 0.3 
47 Sedimentation from PCN site swab No 1 0.3 
48 Drug overdose No 1 0.3 
49 Convulsion and fever No 1 0.3 
50 Raised white cell count No 2 0.6 
51 Poor general condition/low oral No 2 0.6 
intake 
52 Fever after discharged from intensive No 1 03 
care unit 
53 Fever after admission No 2 0.6 
54 Dizziness in leukaemic patient No 1 0.3 
Total 奶 • 
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5.2.2 Types of antibiotic therapy 
Infections and surgical chemoprophylaxis (Nos. 1 to 13 and 32 to 34, 36 in Table 2.1) 
corresponded to 261 empirical therapies, 13 directed therapies (No. 6 and 35 in Table 
2.1) and 2 prophylactic therapies (pacemaker implantation and pacemaker generator 
change, No. 34 in Table 2.1). The remaining indications belonged to 48 unclassified 
therapies (Nos. 14 to 31 and 37 to 54 in Table 2.1). Different antibiotic therapies are 
illustrated graphically in Figure 9. 
Figure 9. Types of antibiotic therapies in a medical ward 
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The classification of community-acquired infection and hospital-acquired infection 
were not recorded in case notes. To ascertain the classification of pneumonia and 
other infections, I referred to patient admission dates and antibiotic starting dates. 
Empirical therapies started on the third day or later were considered as treatment of 
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hospital-acquired infections. All therapies for pneumonia were started within two 
days of admission and were considered to be treatment of community-acquired 
pneumonia. Seventeen empirical therapies were started on the third day of admission 
or later. These included 8 courses for chest infection, one course for chest infection 
and pneumothorax, 4 courses for COAD or infective exacerbation of COAD, one 
course for sepsis, one course for cellulitis, one course for otitis media and one course 
for acute cholangitis. 
5.2.3 Antibiotics prescribed in initial therapy 
In these 324 initial therapies, 367 antibiotics were prescribed. Frequency of use of 
each antibiotic and the percentage are presented in column 2 and column 3 in Table 2.2 
respectively. The frequency of use is broken down into that in monotherapy and that 
in combined therapy, which are given in column 4 and column 5 respectively. Among 
25 different antibiotics prescribed, cefuroxime was the antibiotic prescribed the most 
(390/。)，and was followed in descending order by ampicillin-sulbactam (18.8%), 
co-amoxiclav (11.2%) and amoxycillin (4.6%). 
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Table 2.2 Frequency of use of antibiotics in initial therapy in a medical ward 
Antibiotic Frequency of Percentage Frequency of use Frequency of 
use in initial (%) in single-agent use in combined 
therapy therapy therapy 
Cefuroxime 143 39.0 135 8 
Co-amoxiclav 41 11.2 39 2 
Ampicillin- 69 18.8 67 2 
sulbactam 
Erythromycin 6 1.6 2 4 
Levofloxacin 11 3.0 11 0 
Amoxycillin 17 4.6 11 6 
Ampicillin 11 3.0 2 9 
Cloxacillin 11 3.0 2 9 
Ceftazidime 5 1.4 2 3 
Cefotaxime 2 0.5 2 0 
Metronidazole 10 2.7 0 10 
Isoniazid 5 1.4 0 5 
Pyrazinamide 2 0.5 0 2 
Rifampicin 6 1.6 1 5 
Clarithromycin 10 2.7 4 6 
Ciprofloxacin 4 1.1 4 0 
Ofloxacin 2 0.5 2 0 
Tetracycline 1 0.3 0 1 
Imipenem- 3 0.8 1 2 
cilastatin 
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Table 2.1 continued 
Antibiotic Frequency of Percentage Frequency of use Frequency of 
use in initial (%) in single-agent use in combined 
therapy therapy therapy 
Phenoxymethyl 1 0.3 1 0 
-penicillin 
Ethambutol 2 0.5 0 2 
Cefazolin 2 0.5 2 0 
Acyclovir 1 0.3 0 1 
Ticarcillin- 1 0.3 1 0 
clavulanate 
Cefoperazone- 1 0.3 0 1 
sulbactam 
Total 367 100 289 78 
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5.2.4 Number of antibiotics in initial therapy 
An average of 1.1 antibiotics was prescribed per initial therapy. Almost 90% of initial 
therapies were single agent therapies. However, up to five antibiotics were prescribed 
during the hospital stay (Ampicillin + cloxacillin + Isoniazid + rifampicin + 
ethambutol). Figure 10 shows the number of antibiotics in individual initial therapy. 
Figure 10. Number of antibiotics in initial therapy in a medical ward 
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5.2.5 Prescribing pattern of antibiotics in initial therapy 
Among the 367 antibiotics prescribed in initial therapies, 202 (55.0%) were prescribed 
for treating lower respiratory tract infections (chest infection, pneumonia, aspiration 
pneumonia and COAD or infective exacerbation of COAD). Twenty-seven antibiotics 
(7.4%) were prescribed for treating sepsis. Twelve antibiotics (3.3%) were prescribed 
for urinary tract infection, 15 (4.1%) for tuberculosis, and 11 (3.0%) for bronchiectasis. 
The remaining antibiotics were prescribed for miscellaneous infections or for 
non-infectious diseases. The prescribing patterns of antibiotics in lower respiratory 
tract infections and in sepsis are illustrated graphically in Figure 11 and 12 respectively. 
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5,2,5,1 Prescribing pattern of antibiotics in empirical treatment of lower 
respiratory tract infections 
One hundred and ninety-one patients were diagnosed as having at least one lower 
respiratory tract infection (LRTI) and 202 (55.0%) antibiotics were prescribed 
empirically. The prescribing pattern of antibiotics is shown in Figure 11 (both 
appropriate and inappropriate therapies were included). 
Figure 11. Prescribing pattern of antibiotics in empirical treatment of Lower 
Respiratory Tract Infections in a medical ward (total number of antibiotics=202) 
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* Other antibiotics include rifampicin, clarithromycin, ciprofloxacin and ofloxacin. 
Cefuroxime (39.1%) was the antibiotic prescribed most frequently, followed by 
ampicillin-sulbactam (23.8%) and co-amoxiclav (17.8%). These three antibiotics 
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made up about 80% of antibiotics prescribed empirically for LRUs. 
5.2.5.2 Prescribing pattern of antibiotics in empirical treatment of sepsis 
As recorded in case notes, 29 patients were diagnosed as having sepsis. Thirteen of 
them also had other concurrent infectious diseases. Since antibiotics prescribed for 
two patients were very different from those prescribed for other septic patients, these 
two patients were excluded from the analysis of prescribing patterns. One of these 
patients had sepsis, urinary tract infection and tuberculosis, and imipenem-cilastatin and 
three tuberculosis drugs were prescribed. In another patient who had sepsis and bulla 
disease, cefotaxime was prescribed. 
One antibiotic was prescribed for each of the remaining twenty-seven patients. 
The prescribing pattern of antibiotics in empirical treatment of sepsis as recorded in 
case notes is shown in Figure 12. 
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Figure 12. Prescribing pattern of antibiotics in empirical treatment of 
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Cefuroxime was prescribed empirically in about three-quarters of patients who had 
sepsis. The remaining patients were treated with ampicillin-sulbactam or 
co-amoxiclav. 
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5.2.6 Types of change 
The present study classified 157 first changes, 30 second changes, 12 third changes and 
1 fourth change, resulting in 200 switch therapies. These changes are shown in Table 
2.3. The changes are classified based on different types of change. Intravenous 
route to oral route of administration was most frequently found in first change (n二72) 
and antibiotic change was the overall mostly found type of change (42%). 
Table 2.3 Types of change of antibiotics in a medical ward 
IV to PO PO to IV Dosage Antibiotic Antibiotic Total 
change added change 
change 72 3 4 18 60 157 
2nd change g 1 2 4 15 30 
3rd change 1 0 2 1 8 12 
4th change 1 0 0 0 0 1 
Total(%) 82(41%) 4(2%) 8(4%) 23(12%) 83(42%) 200 
5.2.7 Causes of change 
The causes of change included clinical evidence of improvement after receiving 
antibiotics (45.5%), lack of response to antibiotic treatment (25.5%), alternative 
92 
treatment directed by susceptibility test result (9.5%), grand round review suggesting 
alternative treatment (7.5%) and other miscellaneous causes (12%). The results 
showed that improvement in patient symptom was the main cause for changing the 
therapy, followed by lack of response to antibiotic therapy. Table 2.4 presents the 
causes of change. 
Table 2.4 Causes of switches in antibiotic therapy in patients in a medical ward 
Symptom Not Suscepti- Grand Others* Total 
improved respond bility test round 
ist change 74 43 10 12 18 157 
change 12 6 5 2 5 30 
3rd change 4 2 4 1 1 12 
4th change 1 0 0 0 0 1 
Total(%) 91(45.5%) 51(25.5%) 19(9.5%) 15(7.5%) 24(12%) 200 
年Other causes for changing antibiotic therapy include: new symptoms (9), no cause 
stated (7), allergy to or cannot tolerate previous antibiotic (4), new diagnoses (2), 
conservative treatment for lung cancer (1) and resuming old antibiotic for unknown 
cause (I). 
5.2.8 The relationship between causes of change and types of change 
Causes of change (rows) were tabulated against types of change (columns) to show a 
relationship between the two variables in table 2.5. When a patient showed clinical 
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sign of improvement, the most frequent type of change was to change the route of 
administration from intravenous to oral (n二79). When a patient did not respond to 
antibiotic treatment, the most common practice was to interrupt the existing therapy and 
start a new treatment, namely antibiotic change (n=33). The most frequent change 
after availability of susceptibility test results was also antibiotic change (n=17). 
Antibiotics were usually changed after grand round peer review (n=8). These results 
again show that antibiotic change was the most frequent type of change, followed by 
change in route of administration from intravenous to oral. 
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Table 2.5 Relationship between types of change and causes of change of antibiotic in a 
medical ward 
IV to PO PO to IV Dosage Antibiotic Antibiotic Total 
change added change 
Symptom 79 0 2 0 10 91 
improved 
Not respond 0 2 1 15 33 51 
Susceptibility 0 0 0 2 17 19 
test 
Grand round 2 1 0 4 8 15 
Others 1 1 5 2 15 24 
Total(%) 82(41%) 4(2%) 8(4%) 23(12%) 83(42%) 200 
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5.2.9 Antibiotics prescribed in switch therapy 
In 200 switch therapies, 263 antibiotics were prescribed. In table 2.6, frequency of use 
of each antibiotic and the percentage are given. The frequency of use is grouped as 
monotherapy and combination therapy. Twenty-seven different antibiotics were 
prescribed. Cefliroxime (34.6%) was the most frequently prescribed antibiotic, 
followed by ampicillin-sulbactam (9.9%) and ceftazidime (8.0%). 
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Table 2.6 Frequency of use of antibiotics in switch therapies in a medical ward. 
Antibiotics with more than 5% of switch therapy were highlighted in bold. 
Antibiotic Frequency of use Percentage Frequency of use Frequency of 
in switch therapy (%) in single-agent use in combined 
therapy therapy 
Cefuroxime 91 34.6 70 21 
Co-amoxiclav 8 3.0 7 I 
Ampicillin- 26 9.9 25 1 
sulbactam 
Erythromycin 10 3.8 1 9 
Levofloxacin 9 3.4 7 2 
Amoxycillin 4 1.6 2 2 
Ampicillin 9 3.4 2 7 
Cloxacillin 16 6.1 4 12 
Ceftazidime 21 8.0 13 8 
Cefotaxime 3 1.1 1 2 
Metronidazole 5 1.9 0 5 
Isoniazid 4 1.5 0 4 
Pyrazinamide 4 1.5 0 4 
Rifampicin 4 1.5 0 4 
Clarithromycin 15 5.7 5 10 
Ciprofloxacin 5 1.9 4 1 
Ofloxacin 5 1.9 1 4 
Imipenem- 4 1.5 3 1 
cilastatin 
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Table 2.6 continued 
Antibiotic Frequency of use Percentage Frequency of use Frequency of 
in switch therapy (%) in single-agent use in combined 
therapy therapy 
Ethambutol 4 1.5 0 4 
Cefazolin 1 0.4 0 1 
Rimantadine 1 0.4 0 1 
Cefoperazone- 6 2.3 6 0 
sulbactam 
Cotrimoxazole 1 0.4 0 1 
Cefepime 2 0.8 2 0 
Benzylpenicillin 2 0.8 1 1 
Netilmicin 1 0.4 0 1 
Streptomycin 2 0.8 0 2 
Total 263 100 154 109 
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5.2.10 Number of antibiotics in switch therapy 
On average, 1.3 antibiotics were prescribed per switch therapy. Table 2.7 shows the 
results of the number of antibiotics in switch therapies. Three-quarters of switch 
therapies were single agent therapies (77%). 
Table 2.7 Number of antibiotics in switch therapy in a medical ward 
Number of switch switch switch switch Total (%) 
antibiotic(s) per therapy therapy therapy therapy 
prescription 
1 128 20 5 1 154 (77%) 
2 19 7 6 0 32(16%) 
3 7 3 0 0 10(50/0) 
4 3 0 1 0 4 (2%) 
Total 157 30 12 1 200 
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5.3 Appropriateness of antibiotic therapy 
Forty-eight empirical therapies, nine directed therapies and two prophylactic therapies 
were appropriate. Altogether, 59 (18.2%) antibiotic courses were appropriate. One 
hundred and sixty-seven (51.5%) courses were inappropriate with respect to indications 
and 98 (30.2%) courses were inappropriate with respect to choices of agent. 
The data showed that all dosages, routes of administration and duration of therapy 
were appropriate. Assessment of indications and choices of agent is given in 
Appendix 2. Section 5.3.1 to Section 5.3.4 summarize the assessment results of 
different therapies. 
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5.3.3 Appropriateness of prophylactic therapies 
Forty-eight (18.4%) empirical therapies were appropriate. The major problems were 
inappropriate indications and inappropriate choices of agent. One hundred and 
nineteen courses of antibiotic therapies for chest infection were considered to be 
inappropriate with respect to indication. It is because chest infection was not a 
recommended indication in international guidelines and usefulness of antibiotics in 
treating chest infection has not been confirmed by randomized controlled trials. 
Criteria of assessment and results are shown in Table 2.8. 
Table 2.8 Appropriateness of empirical therapies (total二261) in a medical ward 
Type of inappropriate use No. of empirical therapies 
A. Inappropriate indication (initial therapy only) 119 
B. Inappropriate choice of agent (initial therapy only) 94 
C. Inappropriate dosage 0 
D. Inappropriate route of administration 0 
E. Inappropriate duration of therapy 0 
Inappropriate empirical therapies (A+B+C+D+E) 213 
Appropriate empirical therapies (%) 48 (18.4%) 
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5.3.3 Appropriateness of prophylactic therapies 
Thirteen directed therapies for four urinary tract infections and nine Helicobacter pylori 
eradication therapies were prescribed. Four direct therapies were inappropriate with 
respect to choices of agent. Results on assessment are shown in Table 2.9. 
Table 2.9 Appropriateness of directed therapies (total二 13) in a medical ward 
Type of inappropriate use No. of directed therapies 
A. Inappropriate indication (initial therapy only) 0 
B. Inappropriate choice of agent (initial therapy only) 4 
C. Inappropriate dosage 0 
D. Inappropriate route of administration 0 
E. Inappropriate duration of therapy 0 
Inappropriate directed therapies (A+B+C+D+E) 4 
Appropriate directed therapies (%) 9 (69.2%) 
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5.3.3 Appropriateness of prophylactic therapies 
The two prophylactic therapies for pacemaker implantation or generator change were 
both appropriate. Table 2.10 shows the results of assessment. 
Table 2.10 Appropriateness of prophylactic therapies (total=2) in a medical ward 
Type of inappropriate use No. of prophylactic therapies 
A. Inappropriate indication (initial therapy only) 0 
B. Inappropriate choice of agent (initial therapy only) 0 
C. Inappropriate dosage 0 
D. Inappropriate route of administration 0 
E. Inappropriate duration of therapy 0 
Inappropriate prophylactic therapies (A+B+C+D+E) 0 
Appropriate prophylactic therapies (%) ^ 0 00%) 
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5.3.3 Appropriateness of prophylactic therapies 
Unclassified therapies were therapies that were neither prescribed for proven or 
presumed infection nor for surgical chemoprophylaxis. All unclassified therapies 
were inappropriate owing to inappropriate indications. Results are shown in Table 
2.11. 
Table 2.11 Appropriateness of unclassified therapies (total二48) in a medical ward 
Type of inappropriate use No. of unclassified therapies 
A . Inappropriate indication (initial therapy only) 48 
B . Inappropriate choice of agent (initial therapy only) 0 
C. Inappropriate dosage 0 
D. Inappropriate route of administration 0 
E. Inappropriate duration of therapy 0 
Inappropriate unclassified therapies (A+B+C+D+E) 48 
Appropriate unclassified therapies (%) 0 (0%) 
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5.4 Clinical outcomes of treatment 
Figure 13 shows the clinical outcomes of treatment. In 96.6% of antibiotic courses, 
patients were discharged home or discharged for rehabilitation (discharged). Five 
patients died during their antibiotic treatments in medical wards. 
Figure 13. Clinical outcome of treatment in an audit of use of antibiotics 
in a medical ward 
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""Causes of death: cardiac arrest (1), cerebrovascular accident (1) and unknown (I) 
""""Others: not infection (2), cause not stated (1), patient missing from ward (I), patient 




This chapter discusses in depth various aspects of misuse of antibiotics in the medical 
wards of the Prince of Wales hospital. This chapter is organized as follows. Section 
6.1 discusses the limitations of the present study. Section 6.2 discusses the methods of 
the present study. Section 6.3 discusses patient demographic data, patterns of use, and 
misuse of antibiotics. Section 6.4 is a conclusion of the present study. 
6J Limitations^ 
In this audit of antibiotic prescription in medical wards, cost of antibiotic courses were 
not calculated. Seasonal change is another issue when surveying the usage pattern of 
antibiotics. However, seasonal changes were not taken into account in this 
cross-sectional study. 
In Hong Kong, national guideline was lacking at the time of the audit. Therefore, 
an antibiotic reference guideline was developed to serve as the standard of antibiotic 
‘I thank Professor Clive S. Cockram for his useful comment on the final draft. 
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use and was used to assess antibiotic therapies. High frequency of inappropriate use 
of antibiotics in medical wards was observed. It might be related to the difficulty of 
direct comparison between local practice and recommendations of British and 
Australian experts. Availability of drugs and drug costs were different between Hong 
Kong, Britain and Australia. Disease patterns and susceptibility of antibiotics were 
also different. The results that antibiotic therapies were highly inappropriate were 
calculated based on assessment using international guidelines. 
Another factor affecting the interpretation of the assessment results was that 
adherence to guidelines did not guarantee appropriate use of antibiotics. Patient 
factors and drug factors should be incorporated into the decision-making process of 
antibiotic use. Although guidelines provided options for specific infections, the actual 
practice could be more complicated. 
Antibiotics recommended by family, nurses and pharmacists might affect doctors' 
drug choices. These factors were not documented in case notes. These unspoken 
reasons also influenced doctors' judgement in wards. An assessment based on review 
of case notes might not accurately reflect these important factors. 
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One prominent feature in this audit related to the quality of documentation of 
clinical information which was often confusing. Doctors used a lot of abbreviations, 
which made interpretation of information difficult. Information was not well 
categorized and clearly delineated to allow easy reference. For example, diagnoses 
were not easily identified in doctor's notes. In order to ascertain the indications, it 
would require thorough review of the case notes. In the busy setting of the medical 
wards, it was difficult to review all case notes in an uninterrupted manner when doctors 
and nurses needed to use the case notes frequently. When patients were discharged, 
their case notes were returned to the central record office quickly before data collection 
was completed. Often, patient discharge details and clinical information were 
retrieved from the Hospital Authority Intranet after the episode of hospitalization. 
The present study did not involve interviewing prescribers and data were collected 
by reviewing case notes. When antibiotics were prescribed and there was no evidence 
based on review of case notes to support the diagnosis of infection or need of surgical 
of medical prophylaxis, the present study regarded these therapies as inappropriate. 
Due to the frequently incomplete documentation of information in case notes, the 
proportion of inappropriate therapies might have been over-estimated. 
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The results did not infer that local practice was incorrect or wrong. Antibiotic 
guidelines were available in local settings in Hong Kong. These guidelines 
represented different opinions on use of antibiotics among communities of medical 
professionals in Hong Kong. Local guidelines showed disagreement with 
international guidelines. The most prominent example concerned cefuroxime use. 
The Queen Mary hospital guideline recommended cefuroxime for chronically-ill 
elderly patients having community-acquired pneumonia and for septicaemia (Kumana 
et al., 1991) and the Impact guideline recommended cefuroxime as alternative 
antibiotic in treating hospital-acquired pneumonia and community-acquired liver 
abscess when the preferred regimens were contraindicated (Ho et al., 2001). The 
Australian antibiotic guidelines did not explicitly recommended cefuroxime as an 
option for treatment of infection. For the management of community-acquired 
pneumonia and acute exacerbation of chronic obstructive pulmonary disease in hospital, 
the British Thoracic Society recommended that second- or third-generation 
cephalosporins should be chosen when first-line antibiotics such as amoxicillin were 
contraindicated or when patients did not respond to first-line antibiotics (Pneumonia 
Sub-committee of the Research Committee of the British Thoracic Society, 1993; The 
COPD Guidelines Group of the Standards of Care Committee of the BTS, 1997). 
Different recommendations showed different opinions on use of antibiotics. Different 
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guidelines might adopt different options for various reasons. Local practice could be 
different from the recommendations of Australian and British experts. 
6.2 Method 
6.2.1 Symptom improved and not responded 
I referred causes of antibiotic change due to “improved symptoms" when improvement 
in patients' clinical progress was recorded in case notes. For example, words like 
‘afebrile，，‘no SOB', 'chest clear', and ‘BP stable, no fever' were regarded as 
indicating improvement in symptoms. In some cases, doctors recorded the value of 
clinical indices such as white cell count (WCC) and percentage of arterial oxygen 
saturation (SaO�). In other words, causes of antibiotic change were “improved 
symptoms” if the value was normalized or was within normal range, and antibiotic 
therapy was changed afterwards. 
Deteriorated clinical progress was regarded as “not responded". This was 
suggested by record in case notes by doctors items such as ‘still SOB，，'high fever', 
'SOB again, still swinging fever', 'develop fever', 'develop chills and rigor' and 
110 
‘condition deteriorated, fever 39.2 When antibiotic therapies were changed 
afterwards, I regarded the causes of switch in therapy as "not responding to antibiotic 
treatment". 
6.2.2 Grand round 
Quality assurance is important in providing quality patient care and peer review and 
discussion was a recognized mechanism of quality assurance. According to my results, 
7.5% switch therapies were prescribed after grand round of senior doctors. This figure 
demonstrated that second opinion from a senior staff was an important factor in 
deciding antibiotic therapy for patients. However, it is difficult to assess the 
appropriateness of an antibiotic treatment without documentation of doctor's 
justification of revision. 
6.2.3 Susceptibility test result 
Apart from directing antibiotic treatment, susceptibility test results also suggest 
alternative antibiotics. Results of 185 microbiological test were recorded. Negative 
results such as no growth, no acid-fast bacilli (AFB), commensal cultured, normal flora 
111 
cultured and so on were reported by microbiological department in 123 (70.70/0) tests 
(see Appendix 3 for the summary of culture test results). Positive results gave rise to 
4 directed therapies (all were urinary tract infections) and 19 switch therapies (17 were 
new antibiotics or new combinations of antibiotic prescribed and 2 were antibiotics 
added to original prescriptions). In the remaining cases which had positive results, 9 
prescriptions were issued to change the therapies. The causes of change were as 
follows. Three prescriptions were later issued to change antibiotic therapies from 
intravenous to oral due to improvement in patients' clinical progress, 4 prescriptions 
were issued to change the antibiotics due to lack of response to the original 




The majority of these patients receiving antibiotic courses in medical wards were 
elderly (mean ages were 69.1±14.0 years and 74.3±16.2 years for male and female 
patients respectively) and had multiple medical problems (number of chronic diseases 
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per patient was 1.4) with respiratory tract infection as the main morbid condition in 
these patients. This was followed by sepsis and urinary tract infection. 
6.3.2 Pattern of use 
6.3.2.1 Types of therapy 
A high proportion of antibiotics was prescribed empirically. Two hundred and 
sixty-one (80.6%) therapies were empirical therapies and only thirteen (4.0%) were 
directed therapies. In the medical wards, two (0.6%) prophylactic antibiotic therapies 
were prescribed. The remaining therapies could not be classified (14.8%). 
6.3.2.2 Site of infection 
A high proportion of antibiotics was prescribed for respiratory tract infection in Hong 
Kong. Results obtained from medical wards showed that upper and lower respiratory 
tract infections accounted for 62.6% of all indications. Pneumonia is one of the 
leading causes of death in Hong Kong society. According to the 1997 annual report of 
the Department of Health, the three most life-threatening diseases were malignant 
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neoplasm, heart diseases and pneumonia. 
6.3,2,3 Prescribing pattern of antibiotics in initial therapy 
The present study recorded unusual prescribing patterns of antibiotics. Firstly, as 
recorded in case notes, antibiotics were prescribed for patients who had chest infection. 
Chest infection was an ill-defined condition, and prescription of antibiotics should be 
justified. Antibiotics prescribed for chest infection was reported by an antibiotic 
survey in a hospital in the UK (Moss et al, 1981b). The researchers regarded chest 
infection as equivalent to lower respiratory tract infection and reported that in a district 
general hospital, almost 40% of in-patients over 81 years old were prescribed 
antibiotics for chest infection (Moss et al, 1981b). In the present study, 35.8% 
antibiotic therapies were prescribed for chest infection. However, chest infection is 
not a recommended indication according to international guidelines. 
Secondly, cefuroxime was prescribed empirically for lower respiratory tract 
infection and sepsis. Prescribing patterns of antibiotic for treatment of lower 
respiratory tract infection and sepsis are shown in Figure 11 and Figure 12 respectively. 
Figure 11 shows that cefuroxime was the most frequently prescribed antibiotic for 
114 
empirical treatment of lower respiratory tract infection. This prescribing pattern was 
different from that of Australia and the UK where penicillins were prescribed most 
frequently for lower respiratory tract infection (Harvey et al, 1983; Raymond et al, 
1989; Moss et al, 1981b). Figure 12 shows that cefliroxime, co-amoxiclav or 
ampicillin-sulbactam monotherapy were prescribed empirically for patients who had 
sepsis. Based on my extensive review of surveys on hospital antibiotic use, similar 
prescribing pattern of antibiotics has not been reported. 
63,2,4 Relationship between types and causes of change 
Among 324 courses of treatment, 200 changes were recorded by myself. Change of 
antibiotics and change of intravenous to oral route of administration were the two major 
types of change (42% and 41% changes respectively). The pattern was that when 
patients showed no responses to antibiotic therapy, antibiotic was changed, or when 
patients showed clinical sign of improvement, route of administration was changed 
from lY to PO. In only a small number of cases, antibiotics were added to the old 
prescription (12%). Change in antibiotic dosage was not frequent (4%). Other 
causes of change were seen in a small number of therapies where antibiotics were 
changed following results from culture and susceptibility test and some treatments were 
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changed after being reviewed by senior doctors during grand round. Despite our 
pharmacy training that patients should take the whole course of antibiotics, results of 
this study showed that in wards, antibiotic treatments were often interrupted by doctors 
in response to patients' clinical progress. 
I propose the following explanation for these observations. Doctors generally 
respond to treatment failure of antibiotics by switching to another agent. When a 
patient's disease is not improved after receiving antibiotics, doctors will discontinue the 
existing antibiotics and prescribe a new prescription instead. When a patient's general 
condition improves, intravenous antibiotics are changed to oral antibiotics. 
A randomized controlled trial showed that early intravenous to oral switch therapy 
for community-acquired pneumonia was clinically effective and it minimized hospital 
stay (Guardiola, Rodriguez & Simon et al, 2001). However, there is no prospective 
evaluation on the effects of replacing antibiotics during treatment and/or switching of 
agents on clinical outcome or hospital stay. Neither had these data been 
systematically reviewed nor reported in literature. In a hospital in Shanghai, China, 
40% patients received three or more courses of antibiotics (Tong et al, 1991). In a 
hospital in the UK, an antibiotic audit reported that there were unnecessary changes or 
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additions of antibiotics made to treatment when the sensitivity of the pathogens were 
assessed (Swindell et al, 1983). Our results showed that most changes of antibiotics 
were not directed by microbiological evidence, but was based on clinical ground or on 
practitioners' subjective judgement of the disease. Further studies are called for to 
validate changes of antibiotics before completion of the whole course. 
6.3.3 Appropriateness of antibiotic therapies 
The present study showed that inappropriate indications and inappropriate choice of 
agent were serious problems of antibiotic use in medical wards, although all antibiotic 
dosages were within safety range and routes of administration of antibiotics were 
appropriate. 
The followings subsections of Misuse of empirical therapy discuss different 
aspects of misuse of antibiotics. Some important considerations in interpreting 
assessment results of directed and prophylactic therapies are discussed in Appropriate 
use of directed therapy and Appropriate use of prophylactic therapy. The problems of 
unnecessary use are discussed in Excessive use of unclassified therapy. Appendix 2 is 
a summary of assessment results of each initial therapy, to facilitate in-depth 
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examination of individual therapy. 
6,3,3.1 Misuse of empirical therapy 
Eighty per cent of empirical therapies were inappropriate. The main problems of use 
were inappropriate indications and inappropriate choices of agent. Remarkable 
examples were the inappropriate use of antibiotics in lower respiratory tract infection 
and in sepsis, and the misuse of cefuroxime and third generation cephalosporins. 
INAPPROPRIATE USE OF ANTIBIOTICS IN LOWER RESPIRATORY TRACT 
INFECTION 
Chest infection was not a recommended indication by international guidelines and 
usefulness of antibiotics for treating chest infection has not been confirmed by 
randomized controlled trials. One hundred and nineteen courses of antibiotic 
prescribed for chest infection (Therapies 1 to 116, 119, 126 and 127 in Appendix 2j 
were considered to be inappropriate with respect to indication. 
Cefuroxime was the main stay of treatment of chest infection in medical wards. 
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The antibiotic was prescribed in 55 initial therapies for chest infection. It was 
prescribed either alone or in combination with erythromycin or metronidazole 
(Therapies 1 to 55 in Appendix 2). These therapies amounted to one-sixth of total 
antibiotic therapies in the present study. There were high rate of penicillin-resistant 
Streptococcus pneumoniae and high rate of beta-lactam-resistant Haemophilus 
influenzae in Hong Kong (Felmingham et al., 2000). It might explain the use of 
cefuroxime in treating chest infection. 
When reviewing the recommendations of international and local guidelines, 
namely the Australian antibiotic guidelines (Writing group for therapeutic guidelines: 
antibiotics, 1998), the Queen Mary hospital antibiotic guideline (Kumana et al., 1991) 
and the Impact guideline (Ho et al., 2001), the Queen Mary hospital guideline 
recommended using cefuroxime for elderly or chronically ill patients having 
community-acquired pneumonia in the chapter of chest infection, and the Australian 
antibiotic guidelines and the Impact guideline did not adopt chest infection as an 
indication. The recommendation of the Queen Mary hospital guideline might also be 
explained by the high rates of penicillin-resistant Streptococcus pneumoniae and 
beta-lactam-resistant Haemophilus influenzae in Hong Kong. 
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INAPPROPRIATE USE OF ANTIBIOTICS IN SEPSIS 
Incomplete documentation of clinical status was a problem in medical wards, for 
example, the sites of infection were not specified in case notes before diagnosing sepsis. 
As an auditor, it is difficult to decide the sites of infection without positive 
microbiology. Sepsis is often used loosely by doctors in situations where infections 
are suggested by the presence of fever or high white cell count but not accompanied by 
positive culture and other clinical evidence indicating sites of infection, for example, 
the chest X-ray was normal, patients did not have chest symptoms, examination of 
urine showed negative results and liver function tests were normal". On the other 
hand, septicaemia referred to the presence of bacteria in the blood culture. Sepsis was 
used loosely as a diagnosis when antibiotics were prescribed. 
Cefuroxime was again the main stay of treatment in medical wards. Fifteen 
patients were diagnosed as having sepsis and cefuroxime was prescribed empirically for 
ten patients (Therapies 205 to 214 in Appendix 2). Five patients were diagnosed as 
having both chest infection and sepsis and all of them were treated with cefuroxime 
(Therapies 120 to 124 in Appendix 2). Two patients had sepsis and pneumonia and 
”Chan, J.C.N. E-mail to author, 6 November 2002. 
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they both received cefuroxime empirical treatment (Therapies 141 to 142 in Appendix 
2). Five patients were diagnosed as having sepsis and urinary tract infection by 
doctors and four were treated with cefuroxime (Therapies 220 to 223 in Appendix 2). 
Prescription of cefuroxime for sepsis was inappropriate with respect to choice of agent 
(n=21). Another problem of choosing antibiotic was the prescription of 
ampicillin-sulbactam (Therapies 216 to 219 and 224 in Appendix 2) and co-amoxiclav 
(Therapy 215 in Appendix 2) to treat sepsis. Ampicillin-sulbactam and co-amoxiclav 
were not recommended choices in international guidelines and were inappropriate 
(n=6). Overuse of cefliroxime meant the underuse of third-generation cephalosporins 
in treating sepsis. 
Sepsis was not adopted as an indication by the Queen Mary hospital guidelines. 
When referring to septicaemia, cefuroxime is one of the typical regimens recommended 
and the other regimens were ceftazdime or pipercillin plus an aminoglycoside and 
vancomycin plus either an aminoglycoside or ciprofloxacin or aztreonam (Kumana et 
a/., 1991). The Australian antibiotic guidelines recommended intravenous cloxacillin 
plus gentamicin for normal adults having septicaemia (Writing group for therapeutic 
guidelines: antibiotics, 1998). Sepsis was not an adopted indication in the Australian 
antibiotic guidelines. The Impact guideline did not specify use of antibiotics in sepsis 
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or septicaemia. To conclude, the Queen Mary hospital antibiotic guideline 
recommended use of cefuroxime in septicaemia, Australian antibiotic guidelines did not 
adopt sepsis as an indication and the Impact guideline did not specify the use of 
antibiotics. 
MISUSE OF CEFUROXIME 
Cefuroxime was the antibiotic prescribed most frequently in both initial and switch 
therapies (in initial therapies, cefiiroxime made up 39% of antibiotics; in subsequent 
therapies, cefuroxime accounted for 34.6% of total antibiotics). 
Cefuroxime was the most frequently used antibiotic in treating pneumonia in 
medical wards. The prescriptions were assessed as inappropriate with respect to 
choice of agent. Sixteen patients were having pneumonia. Two of them were also 
having sepsis or bronchiectasis. Seven of these patients received cefiiroxime as 
empirical treatment (Therapies 128 to 132 and 141 to 142 in Appendix 2). In the 
remaining cases, co-amoxiclav, ampicillin-sulbactam, erythromycin, metronidazole, 
levofloxacin, cefotaxime, cefoperazone-sulbactam, and cloxacillin were prescribed for 
one or two patients (Therapies 133 to 140 and 143 in Appendix 2). All pneumonia 
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therapies were started within two days of admission to medical wards. 
The main pathogens of community-acquired pneumonia were Streptococcus 
pneumoniae and Haemophilus influenzae. The Department of Health of Hong Kong 
reported rate of penicillin resistance in Streptococcus pneumoniae in community setting. 
Mid-stream urine specimens, throat swabs, nasal swabs and stool specimens were 
contributed by doctors in the private sector or in government general out-patient clinics 
and of 10 isolates of Streptococcus pneumoniae tested, one was penicillin-resistant (Ma 
et al., 2001). For Streptococcus pneumoniae isolated from nasopharyngeal swab 
samples of children attending kindergarten or day care center, or isolated from hospital 
sputum or blood cultures, 55.8% to 58.2% were of reduced susceptibility to penicillin 
(Chiu, Ho & Chow et al., 2001; Lyon, Scheel & Fimg et al., 1996). In Hong Kong 
community, Streptococcus pneumoniae was still susceptible to penicillin. A 
three-month audit of antimicrobial treatment of community-acquired pneumonia in the 
medical wards of the Prince of Wales hospital reported that Haemophilus influenzae 
was the most common bacterium isolated from sputum samples of patients having 
community-acquired pneumonia in medical wards (You et al., 2002). Sputum 
samples were collected from 156 patients for culture and susceptibility testing. 
Bacteria were isolated in 35 (22%) patients (You et al. ’ 2002). The number of isolates 
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of Haemophilus influenzae and susceptibilities of the pathogen were not reported by the 
study. In a retrospective review of computer record of all microbial isolates from 
1986 to 1993, the Queen Mary hospital reported that for Haemophilus influenzae 
isolated from the respiratory tract, the resistance rate for ampicillin increased 
significantly from 17.0% to 29.0% from 1986 to 1993. However, almost all 
Haemophilus influenzae isolated remained sensitive to co-trimoxazole (Ho, Yuen & 
Yam et al., 1995). According to the Alexander project, in 116 and 135 isolates of 
Haemophilus influenzae tested in 1996 and 1997, the percentage of isolates producing 
beta-lactamase in Hong Kong were 37.1% and 28.9% respectively (Flemingham et al., 
2000). In Hong Kong, Haemophilus influenzae was still susceptible to beta-lactams 
such as ampicillin and amoxycillin. Cefuroxime was used excessively in treating 
community-acquired pneumonia in medical wards. 
Apart from chest infection and sepsis, cefuroxime was also used in chronic 
obstructive airway disease or infective exacerbation of chronic obstructive airway 
disease (Therapies 149 to 163 in Appendix 2). The high resistance rate in 
Streptococcus pneumoniae and Haemophilus influenzae in Hong Kong (Felmingham et 
al., 2000) might also be the reason of choosing cefuroxime in treating chronic 
obstructive airway disease. The place of therapy of cefuroxime was given by the 
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British Thoracic Society. The Society recommended amoxycillin or tetracycline as the 
first choice antibiotics for the management of acute exacerbation of COPD in hospital 
unless the antibiotics had been used with poor response prior to admission, and broad 
spectrum cephalosporin or one of the newer macrolides should be considered if patients 
did not respond to the first choice agents (The COPD Guidelines Group of the 
Standards of Care Committee of the BTS, 1997). 
The prescription of cefuroxime in treating a patient with aspiration pneumonia 
calls for attention (Therapy 144 in Appendix 2). The antibiotic is not an antibiotic of 
choice for anaerobes which are the main organisms involved in aspiration pneumonia. 
Metronidazole is the preferred therapy for anaerobic infection. 
In empirical treatment of urinary tract infection, cefuroxime was frequently 
prescribed (seven out of eight cases of UTI, Therapies 227 to 233 in Appendix 2). 
However, culture test results in other patients in the present study showed that 
pathogens isolated from urine specimens were also frequently susceptible to ampicillin, 
co-amoxiclav and cotrimoxazole (Therapies 312 to 315 in Appendix 2). 
Cefuroxime was prescribed for treating two patients who had CNS infection 
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(Therapies 259 to 260 in Appendix 2). Although this antibiotic penetrates into 
cerebrospinal fluid (CSF) adequately through the inflamed meninges, third generation 
cephalosporins are preferred for this life-threatening infection (American Medical 
Association Department of drugs, 1991). Cefuroxime were an inappropriate choice in 
treating meningitis. 
In treating acute cholangitis, a combination of cefuroxime, ampicillin and 
metronidazole was prescribed (Therapy 256 in Appendix 2). Since coliforms and 
enterococci were the most common organisms isolated, intravenous ampicillin and 
cephalosporin should be given; metronidazole might be added if anaerobes were 
isolated in the blood (Sung, 1998). As a cephalosporin, cefuroxime was appropriately 
chosen. However, the simultaneous use of metronidazole without positive culture was 
inappropriate. 
Cefuroxime was also prescribed in various uncommon combinations with other 
antibiotics, such as co-amoxiclav, erythromycin, ampicillin plus cloxacillin, ampicillin 
alone, cloxacillin alone, ceftazidime plus clarithromycin, tuberculosis drugs and 
metronidazole. Since first-line agents and combinations of first-line agent should be 
chosen for empirical treatment, these combinations were inappropriate choices. 
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MISUSE OF THIRD GENERATION CEPHALOSPORIN 
Ceftriaxone, being equally effective as cefotaxime, was not prescribed during the entire 
study period. Apart from underuse of ceftriaxone, third generation cephalosporins 
were generally misused in the following prescriptions. Ceftazidime was prescribed for 
empirical treatment of aspiration pneumonia (Therapies 146 and 147 in Appendix 2). 
Cefotaxime was used empirically in treating pneumonia (Therapy 140 in Appendix 2). 
Cefoperazone-sulbactam was prescribed for patients with both pneumonia and 
bronchiectasis (Therapy 143 in Appendix 2). 
Ceftazidime was indicated for treating infective exacerbation of bronchiectasis 
(Therapies 251 to 252 in Appendix 2) because Pseudomonas aeruginosa was the most 
frequently isolated pathogen from sputum samples of patients having bronchiectasis 
(Chan, Ho, Lai et al, 1996; Ho, Chan, Ip et al., 1998). In a study conducted at our 
hospital, Pseudomonas aeruginosa was found to be the organism isolated most 
frequently from sputum of hospitalized patients with infective exacerbation of 
bronchiectasis in Hong Kong (Chan et al, 1996). In another study conducted at the 
outpatient respiratory clinic in the Queen Mary hospital, the same organism, 
Pseudomonas aeruginosa, was found to be the predominant pathogenic bacteria 
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isolated (Ho et al, 1998). In the Queen Mary hospital study, sputum samples were 
collected outside periods of infective exacerbation, which reflected steady-state 
bronchiectasis in Chinese patients. When reviewing the recommendations of 
guidelines, bronchiectasis was not an indication in the Australian antibiotic guideline. 
In the Queen Mary hospital guideline, oral amoxicillin was recommended for mild 
cases of infective episodes of bronchiectasis. When patient failed to respond to oral 
amoxicillin, oral ofloxacin should be chosen. In moderate to severe cases, parenteral 
second- or third-generation cephalosporin was recommended (Kumana et al., 1991). 
In the recent Impact guideline, oral ciprofloxacin, intravenous ticarcillin-clavulanate or 
intravenous piperacillin-tazobactam was recommended and an aminoglycoside could be 
added to the regimen (Ho et al., 2001). Since Pseudomonas aeruginosa was involved 
in exacerbation of this chronic disease, the use of quinolone and ceftazidime in treating 
infective exacerbation of bronchiectasis was appropriate. 
Another example of appropriate use of third generation cephalosporin was the 
prescription of cefotaxime in treating sepsis and bulla disease (Therapy 225 in 
Appendix 2) because cefotaxime was an appropriate agent for patients with septicaemia 
that was of respiratory causes. Combined therapy with erythromycin was 
recommended in the Australian antibiotic guidelines to cover Streptococcus 
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pneumoniae, Legionella pneumophila, Haemophilua influenzae and Gram negative 
bacteria such as Klebsiella pneumoniae (Writing group for therapeutic guidelines: 
antibiotic, 1998). However, omission of erythromycin from the prescription was still 
considered appropriate since the presumed infection Legionnaires' disease was very 
rare in Hong Kong. For example in 2000, only two sporadic cases were reported to 
the Department of Health of Hong Kong (Mok, 2001). 
6.3.3.2 Appropriate use of directed therapy 
Of the four directed UTI therapies prescribed after microbiological test had confirmed 
the presence of bacteria in patient urine specimens, only one therapy was inappropriate. 
Ofloxacin was prescribed to treat one patient whose catheter urine specimen grew 
Group B Streptococci, which was a rare pathogen in urinary tract infection (Therapy 
315 in Appendix 2). The isolated strain was sensitive to ampicillin and cotrimoxazole. 
No information on the resistance of the micro-organism was available. The use of 
ofloxacin in this patient was inappropriate since it did not follow the results of 
susceptibility test. 
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Cefuroxime was chosen instead of the less expensive but equally effective 
antibiotics in directed UTI therapies. In a patient, strain of Proteus mirabilis sensitive 
to ampicillin, cefuroxime and cotrimoxazole was isolated from catheter urine specimen 
(Therapy 312 in Appendix 2). Cefuroxime was prescribed and was appropriate 
because the antibiotic is delivered to the urinary tract in active form. Similarly, 
cefuroxime was chosen instead of other less expensive but equally effective antibiotics 
in other directed therapies (Therapy 313 in Appendix 2). I regarded this course as 
appropriate because cefuroxime was one of the effective choices. 
6.3,3.3 Appropriate use of prophylactic therapy 
The only prophylactic use of antibiotics therapy in the present study was cefazolin 
prescribed before pacemaker implantation and generator change (Therapies 262 and 
263 in Appendix 2). Since patients were transferred to other departments for the 
procedure, the duration of therapy could not be tracked. Cefazolin was an appropriate 
choice and the dosage and route of administration were appropriate; therefore the two 
prophylactic therapies were appropriate. 
There are no standardized methods of assessing chemoprophylactic therapies. 
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Different antibiotic usage reviews used different criteria for assessment. For example, 
antibiotic surveys in the UK, duration of antibiotic prophylaxis was appropriate when it 
was given for less than or equal to twenty-four hours (Moss et al, 1981a; Griffiths et 
al., 1986b). In Canada, when prophylactic parenteral antibiotics were given for longer 
than five days, the dosage was inappropriate (Achong et al., 1977b). 
6.3.3,4 Excessive use of unclassified therapy 
Forty-eight (14.8%) antibiotic courses could not be classified into empirical, directed or 
prophylactic therapies because no anatomical sites of infection, types of surgical 
chemoprophylaxis and isolated pathogens could be found based on review of case notes. 
The indication was unclear and documentation of clinical status was incomplete. 
The data indicated that doctors prescribed antibiotics without clinical evidence in 
three situations. Firstly, antibiotic therapies were prescribed in non-infectious diseases. 
Examples included lung cancer, asthma, bulla disease, skin rash and so on. Secondly, 
antibiotic courses were prescribed in situations where only patient signs and symptoms 
were recorded. These clinical presentations included hyperinflated lung, unproductive 
cough, facial erythema, hypothermia, knee pain, wound pain and so on. Thirdly, as 
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recorded in case notes antibiotics was prescribed for a patient who had an unknown 
condition, sedimentation of percutaneous nephrotomy (PCN) site swab (Therapy 301 in 
Appendix 2). These therapies were considered to be inappropriate with respect to 
indication. 
Similar results were obtained in a Liverpool teaching hospital in the UK, where 
antibiotic courses were prescribed for multiple fracture, tramatic haematuria, urinary 
catheter insertion, Candida prophylaxis, skull fracture, and so on in order to prevent 
endocarditis or bacteraemia (Griffiths et al., 1986a). In China, antibiotics were 
prescribed for non-infectious diseases and for unknown indications (Tong et al., 1991). 
The unnecessary use of antibiotic was explained by Kunin et al (1973). The 
investigators described antibiotic as a drug of fear. Doctors wanted to help their 
patients despite the uncertainties of diagnosis and management, and believed that if a 
drug did some good and was unlikely to do harm, it might be tried even when it was not 
necessary. 
It is good clinical practice to document indications when antibiotics are prescribed. 
Antibiotics started without clear indications do no more good than harm in the long run. 
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For example, when the patient is re-admitted, it will be unreliable to prescribe an 
empirical antibiotic treatment based on the patient's previous medical history or 
outcome of previous antibiotic use. Moreover, overuse of antibiotics exposes patients 
to unnecessary risks of drug interactions and adverse reactions of antibiotics. 
Irrational prescribing of antibiotics lead to treatment failure, and treatment failure 
explain interruption of treatment and starting new antibiotic therapies. Eventually, 
prescription of antibiotic without a clear indication turns out to be inappropriate. 
To summarize, the problem of antibiotic use was two-fold. Firstly, guidelines 
were developed when evidence of clinical practice was inadequate. Lack of 
evidence-based medicine and low adherence to guideline led to inappropriate antibiotic 
use. For example, sepsis was used loosely as a diagnosis when antibiotics were 
prescribed and cefuroxime was used excessively. Secondly, the incomplete 
documentation of clinical data such as sites of infection has worsened the standard of 
practice. 
6.3 A Clinical outcome of treatment 
In the present study, 96.6% patients were either discharged home or discharged to other 
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health care facilities. Although the clinical outcome of treatment was satisfactory, the 
use of antibiotics was not satisfactory. It is because of the high percentage of 
inappropriate antibiotic therapy and the fact that antibiotic therapies were changed up to 
four times in an average of nine days (the average length of stay of subject patients in 
the present study). 
6,4 Conclusion 
The present study involved collection of data through reviewing patients' case notes. 
Data were collected to examine the prescribing pattern of antibiotics in medical wards, 
change of antibiotic treatments and the problems of antibiotic use. Antibiotics were 
mainly prescribed to treat lower respiratory tract infections (LRTI), followed by sepsis 
and urinary tract infection (UTI). Cefuroxime was the most frequently prescribed 
antibiotic. I observed that doctors generally responded to treatment failure by 
switching to another treatment. When patients showed clinical evidence of 
improvement, intravenous antibiotics are changed to oral antibiotics. The data 
indicated that doses of antibiotics, routes of administration and duration of therapies 
were appropriate. However, 51.5% of antibiotic courses were inappropriate with 
respect to indications and 30.2% of antibiotic courses were inappropriate with respect 
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to choices of antibiotic, according to the standard of the reference guideline. These 
findings were consistent with the global problems of antibiotic use, but the percentage 
of inappropriate antibiotic courses was higher in Hong Kong than in developed 
countries. This study highlights the frequent inappropriate use of antibiotics in 
medical wards. At present, different opinions regarding use of antibiotics in chest 
infection and sepsis were found in different guidelines. This situation reflected 
conflicting opinions on use of antibiotics in Hong Kong. Lack of national antibiotic 
guideline in Hong Kong, chest infection and sepsis being used loosely as diagnoses and 




During a two-month study period, I collected data on use of antibiotics in medical 
wards by reviewing patients' case notes and analyzed the pattern of use and 
appropriateness of use of antibiotics. 
The first antibiotic prescriptions given to medical patients was defined as the 
initial therapies. Any change to the initial therapies, namely route change, dosage 
change, and change of antibiotics, were recorded. The revised therapies was defined 
as the switch therapies. The types and causes of change were categorized. 
An antibiotic guideline was developed for the present study. The appropriateness 
of antibiotic therapies was assessed with reference to the antibiotic guideline. When 
the indications, choices of agent, dosages of antibiotics, routes of administration and 
duration of therapies were appropriate, the antibiotic courses were appropriate. 
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The findings are as follows. 
1. Antibiotics were most frequently prescribed for lower respiratory tract infection 
(58.6%), followed by sepsis (8.2%) and urinary tract infection (5.1 %). 
2. Cefliroxime was the antibiotic prescribed most frequently (in initial therapy, 39.0% 
were cefuroxime and in switch therapy, cefuroxime accounted for 34.6% of total 
antibiotics). 
3. High proportion of antibiotics was prescribed empirically. Two hundred and 
sixty-one empirical therapies were prescribed, but only thirteen directed therapies 
and only two prophylactic therapies were prescribed. 
4. The problems of antibiotic use related to indications and choices of antibiotic. In 
51.50/0 of antibiotic courses, the indications were assessed as inappropriate and in 
30.2% of antibiotic courses, the choices of antibiotics were assessed as 
inappropriate. 
5. The data showed that the doses, routes of administration and duration of therapies 
were appropriate. 
6. Antibiotics were prescribed inappropriately in lower respiratory tract infection and 
in sepsis; cefuroxime and third generation cephalosporins were misused. 
7. Documentation of clinical details was incomplete. Based on review of case notes, 
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antibiotic courses were prescribed in non-infectious diseases, were prescribed in 
situations where only patient signs and symptoms were recorded and was 
prescribed for one patient who had an unknown condition. 
8. Antibiotic courses were changed frequently (up to four times) during patients' 
hospital stay, which was nine days on average. 
9. The types of change were change of antibiotics (42%), change of route of 
administration from intravenous to oral (41%), addition of new antibiotics (12%), 
change in dosage (4%) and change from oral route of administration to intravenous 
route (2%). 
10. The causes of change include clinical evidence of improvement after receiving 
antibiotics (45.5%), not responding to antibiotic treatment (25.5%), susceptibility 
test results suggesting alternative treatment (9.5%), grand round review suggesting 
alternative treatment (7.5%) and others (12%). 
11. Change of antibiotics was the most popular type of change when patients did not 
respond to antibiotic treatment. Change of route of administration from 
intravenous to oral was the second most popular type of change when patient 
showed clinical evidence of improvement. 
There were no prior studies that categorized the causes of antibiotic change. I 
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proposed explanations for the change of antibiotics in medical wards. This antibiotic 




The present study shows that a lot of antibiotics were prescribed empirically or were 
prescribed without a clear indication. Forty-eight (14.8%) antibiotic courses could not 
be classified into empirical, directed or prophylactic. In these unclassified therapies, 
presumed or proven infection or surgical prophylaxis was not evident in case notes. 
Antibiotics were prescribed largely based on prescribers, impression of the disease, 
rather than objective evidence such as the presence of signs and symptoms of bacterial 
infection or presence of micro-organism. Since the usefulness of non-surgical 
prophylaxis remains to be proven, prescription of antibiotics should be justified. The 
missing gap between evidence and practice thus gave rise to non-trivial problems that 
prescribers had to solve. More examples of lack of evidence are as follows. 
As there are no universal formats of documenting clinical information and the 
styles of recording prescriptions vary from doctor to doctor, it is difficult to ascertain 
the prescribers' rationale behind the recorded prescriptions. Flaws in epidemiological 
method are therefore not uncommon. Major concerns are the conflicting theories or 
hypotheses regarding the indication of antibiotics, antibiotic misuse and emergence of 
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resistant strains of micro-organisms. So far there has been no evidence from 
randomized controlled trials that compares antibiotic treatment and antibiotic 
non-treatment in patients with signs and symptoms of infection but without 
microbiological proof. Randomized controlled trials are recommended to compare 
values of antibiotic regimens in the treatment of proven or unproven infections. That 
appropriate or inappropriate use of antibiotics leads to the emergence of resistant 
organisms is still a controversial issue due to lack of evidence from randomized 
controlled trials. And finally, the present study demonstrates that doctors and 
hospitals have various subcultures that ground their practices, and such practices are 
often irrational and not well justified. 
As for the solutions, first, consensus on documenting clinical information is 
necessary to facilitate effective exchange of information. Second, standard definitions 
and standardized methodology of epidemiological studies are required so as to yield 
comparable research findings for guiding clinical decisions. Third, randomized 
controlled trials and prospective evaluations should be undertaken to provide solid 
evidence on which clinical practice is based. Fourth, development of national 
antibiotic guidelines and periodic audit is encouraged when evidence for clinical 
practice is limited for the time being. Fifth, education of doctors is recommended. 
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Specific example is to improve clinical documentation in patients' case notes. Clear 
documentation facilitates efficient referencing and improves use of antibiotics in chest 




Appendix 1 Usual adult daily dose range of antibiotics 
Antibiotic Usual adult daily dose range Remark 
amoxycillin 250mg to 500mg bd -
ampicillin 250mg q6h to Ig q8h -
ampicillin-sulbactam 375mg to 12g per day in 2 to 4 -
doses 
benzylpenicillin 1.2g to 7.2g daily in 4 to 6 -
divided doses 
cefoperazone (with or 2g to 8g per day in 2 doses -
without sulbactam) max: 16g per day 
cefotaxime Ig ql2h to 12g per day in 3 to 4 -
doses 
ceftazidime Igto 6g per day in 2 to 3 doses -
ceftriaxone Igto 4g q24h -
cefuroxime PO: 250mg to 500mg bd -
IV or IM: 750mg to 1.5g q6-8h 
ciprofloxacin lOOmg to 400mgql2h -
clarithromycin 250mg to 500mg ql2h 
cloxacillin 250mg to 500mg q6-8h -
max: 8g per day 
co-amoxiclav 250mg (amoxycillin) to -
Ig (amoxycillin) q6-12h 
cotrimoxazole 480mg to 1440mg ql2h -
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Antibiotic Usual adult daily dose range Remark (usual dose 
range for adult 
weighing 70kg) 
ethambutol 15mg/kg to 45mg/kg daily 1 g to 3g daily 
to 3 times a week to 3 times a week 
erythromycin 250mg to Ig q6-12h -
max: 4g per day 
gentamicin 2-5mg/kg/day in 3 doses 140mg per day to 
max: 7.5mg/kg/day 350mg per day 
max: 525mg per day 
imipenem-cilastatin Ig to 4g (imipenem) per day in 3 -
(intravenous) to 4 dose 
isoniazid 15mg/kg per day 1 g per day 
to 3 times a week to 3 times a week 
metronidazole 500mg q8h -
max: 2g per day 
ofloxacin lOOmg q24h to 400mg ql2h -
phenoxymethylpenicillin 500mg to 750mg qid -
pyrazinamide 1.5gto 2.5g daily to -
3 times weekly 
rifampicin 450mg to 600mg qd -
streptomycin Ig per day (reduce to 500mg to -
750mg per day if weight<50kg or 
age>70) 
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Appendix 2 Assessment of indications and choices of agent of initial therapies in an 
audit of 324 antibiotic courses in a medical ward 
Table of appropriateness of empirical, prophylactic and unclassified therapies 
Therapy Indication Antibiotic No. of Appropriateness Type of 
no. prescribed therapies inappropriate 
use 
1-52 chest infection Cefuroxime 52 inappropriate indication 
53-54 Cefuroxime + 2 inappropriate indication 
erythromycin 
55 Cefuroxime + 1 inappropriate indication 
metronidazole 
56-76 Co-amoxiclav 21 inappropriate indication 
77—99 Ampicillin- 23 inappropriate indication 
sulbactam 
100 Ampicillin- 1 inappropriate indication 
sulbactam + 
metronidazole 
101 Erythromycin + 1 inappropriate indication 
ampicillin 
102-103 Levofloxacin 2 inappropriate indication 
104-107 Amoxycillin 4 inappropriate indication 
108 Ampicillin 1 inappropriate indication 
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T h e r a p y I n d i c a t i o n A n t i b i o t i c N o . o f A p p r o p r i a t e n e s s T y p e o f 
n o . p r e s c r i b e d t he rap ies i n a p p r o p r i a t e 
use 
109 chest infection Rifampicin 1 inappropriate indication 
110-111 Clarithromycin 2 inappropriate indication 
112-113 Ciprofloxacin 2 inappropriate indication 
114 Ofloxacin 1 inappropriate indication 
115 chest infection Ampicillin- 1 inappropriate indication 




116 Ampicillin- 1 inappropriate indication 
sulbactam + 
metronidazole 
117 chest infection Cefuroxime 1 inappropriate Choice of 
and TB agent 
118 chest infection Levofloxacin 1 inappropriate Choice of 
and bronchiectasis agent] 
119 chest infection Cefuroxime 1 inappropriate indication 
and pneumothorax 
120-124 chest infection Cefuroxime 5 inappropriate choice of 
4 
and sepsis agent 
3 Ofloxacin is an appropriate antibiotic. 
4 Cefuroxime does not adequately cover Gram negative organism. 
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T h e r a p y I n d i c a t i o n A n t i b i o t i c N o . o f A p p r o p r i a t e n e s s T y p e o f 
no. prescribed therapies inappropriate 
use 
125 chest infection Cefliroxime 1 inappropriate choice of 
and gangrene agent? 
126 chest infection Cefuroxime 1 inappropriate Indication 
and haemoptysis 
127 chest infection Ampicillin- 1 inappropriate Indication 
and pemphigoid sulbactam 
128-131 pneumonia Cefliroxime 4 inappropriate Choice of 
agent 
132 Cefuroxime + 1 inappropriate Choice of 
erythromycin agent 
133-134 Co-amoxiclav 2 appropriate 
135 Co-amoxiclav + 1 inappropriate Choice of 
metronidazole agent^ 
136-137 Ampicillin- 2 appropriate 
sulbactam 
138 Erythromycin 1 appropriate 
139 Levofloxacin 1 inappropriate Choice of 
agent 
140 Cefotaxime 1 inappropriate Choice of 
agent 
5 Coverage of anaerobe is needed. 
6 Do not often add metronidazole in treating pneumonia. 
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n o . p r e s c r i b e d t he rap ies i n a p p r o p r i a t e 
use 
141-142 pneumonia and Cefuroxime 2 inappropriateChoice of 
sepsis agent^ 
143 pneumonia and Cloxacillin + 1 inappropriate Choice of 
g 
bronchiectasis cefoperazone- agent 
sulbactam 
144 aspiration Cefuroxime 1 inappropriate Choice of 
9 
pneumonia agent 
145 Cefuroxime + 1 inappropriate Choice of 
co-amoxiclav agent 
146-147 Ceftazidime + 2 inappropriate Choice of 
metronidazole agent i � 
148 aspiration Co-amoxiclav 1 inappropriate Choice of 





7 Gram negative bacteria is possibly involved in sepsis, gentamicin is indicated. If it is suspected that 
pathogens are originated from the respiratory tract, third generation cephalosporin is indicated. 
8 Staphylococcus aureus is not common in pneumonia or in bronchiectasis exacerbation. 
9 Anaerobe is involved in aspiration pneumonia, metronidazole should be chosen. 
10 Ceftazidime is a third generation cephalosporin normally prescribed for pseudomonal infection. 
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no. prescribed therapies inappropriate 
use 




164-173 Co-amoxiclav 10 appropriate 
174-193 Ampicillin- 20 appropriate 
sulbactam 
194 Erythromycin 1 appropriate 
195-196 Levofloxacin 2 inappropriate Choice of 
agent 
197-202 Amoxycillin 6 appropriate 
203 Ciprofloxacin 1 inappropriate Choice of 
agent 






Therapy Indication Antibiotic No. of Appropriateness Type of 
no. prescribed therapies inappropriate 
use 
205-214 sepsis Cefuroxime 10 inappropriate Choice of 
agent 
215 Co-amoxiclav 1 inappropriate Choice of 
agent 
216-219 Ampicillin- 4 inappropriate Choice of 
sulbactam agent 
220-223 sepsis and UTI Cefliroxime 4 inappropriate Choice of 
agent n 
224 Ampicillin- 1 inappropriate Choice of 
sulbactam agent 
225 sepsis and bulla Cefotaxime 1 appropriate^^ 
disease 
226 sepsis, UTI and Isoniazid + 1 appropriate^^ 




11 Gentamicin is indicated. It is nephrotoxic; hence, close monitoring is needed. 
12 Cefotaxime is an appropriate antibiotic for serious infection that is of respiratory causes, erythromycin 
may be added to cover Legionella pneumophilia. 
13 Streptomycin is too toxic for patient with both UTI and septicaemia. On the other hand, imipenem 
was not associated with nephrotoxicity. Therefore, imipenem-cilastatin is an appropriate choice. 
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Therapy Indication Antibiotic No. of Appropriateness Type of 
no. prescribed therapies inappropriate 
use 
227-233 UTI Cefuroxime 7 inappropriate Choice of 
agent 
234 Ampicillin- 1 appropriate 
sulbactam 
235 prostatitis Co-amoxiclav 1 inappropriate Choice of 
agent 
236 TB Co-amoxiclav 1 inappropriate Choice of 
agent 
237 Ampicillin- 1 inappropriate Choice of 
sulbactam agent 
238-239 Isoniazid + 2 inappropriate Choice of 
rifampicin agent 




241 cellulitis Ampicillin + 1 inappropriate Choice of 
cloxacillin agent ^ ^ 
14 Pathogens usually susceptible to cheaper alternatives such as ampicillin, co-amoxiclav and 
cotrimoxazole. These first line agents should be prescribed. 
Ampicillin is not necessary. 
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no. prescribed therapies inappropriate 
use 
cellulitis and TBAmpic i l l i n + 1 inappropriateChoice of 




243 cellulitis and Ampicillin + 1 inappropriate Choice of 
facial erythema cloxacillin agent 
244 bronchiectasis Cefliroxime 1 inappropriate Choice of 
agent 16 
245 Co-amoxiclav 1 inappropriate Choice of 
agent 
246-250 Levofloxacin 5 inappropriate Choice of 
agent" 
251 Ceftazidime 1 appropriate 
252 Ceftazidime + 1 inappropriate Choice of 
acyclovir agent 
253 Imipenem- 1 inappropriate Choice of 
cilastatin agent 
16 Ps. aeruginosa is the most commonly isolated organism in patient sputum during exacerbation of 
bronchiectasis. Therefore antibiotic that covers Ps. aeruginosa should be prescribed. 
17 Ofloxacin should be prescribed because of its lower price and the same effectiveness. 
Acyclovir is not necessary. 
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Therapy Indication Antibiotic No. of Appropriateness Type of 
no. prescribed therapies inappropriate 
use 
254 otitis media Co-amoxiclav 1 appropriate 
255 upper RTI Ciprofloxacin 1 inappropriate Choice of 
agent 
256 acute cholangitis Cefuroxime + 1 inappropriate Choice of 
ampicillin + agent^^ 
metronidazole 
257 acute cholangitis Ampicillin- 1 inappropriate Choice of 
sulbactam agent 
258 Ticarcillin- 1 inappropriate Choice of 
clavulanate agent 
259-260 CNS infection or Cefuroxime 2 inappropriate Choice of 
,20 
meningitis or agent 
encephalitis 
261 subacute bacterial Ampicillin + 1 inappropriate Choice of 
21 
endocarditis cloxacillin agent 
19 Metronidazole should be added after anaerobes have been isolated in blood, since the main aim of this 
treatment is to control bacteraemia (bacteria in blood). 
20 Third generation cephalosporin preferred for this life-threatening infection. 
21 This regimen does not cover Gram negative organism adequately. 
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264 viral hepatitis Phenoxymethyl- 1 inappropriate indication 
penicillin 
265-267 acute pulmonary Cefuroxime 3 inappropriate indication 
oedema 
268-269 hyperinflated lung Ampicillin- 2 inappropriate indication 
upon chest X-ray sulbactam 
270-271 lung cancer Cefuroxime 2 inappropriate indication 
272 Clarithromycin 1 inappropriate indication 
273-274 haemoptysis Ampicillin- 2 inappropriate indication 
sulbactam 
275 pneumothorax Cefuroxime 1 inappropriate indication 
276 pneumothorax and Ampicillin- 1 inappropriate indication 
wound pain sulbactam 
277 asthma Cefuroxime 1 inappropriate indication 
278-279 Ampicillin- 2 inappropriate indication 
sulbactam 
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Therapy Indication Antibiotic No. of Appropriateness Type of 
no. prescribed therapies inappropriate 
use 
280 bulla disease and Ampicillin- 1 inappropriate indication 
emphysema sulbactam 
281 unproductive Cefliroxime 1 inappropriate indication 
cough 
282 pleural effusion Cefuroxime 1 inappropriate indication 
283 Amoxycillin 1 inappropriate indication 
284 skin rash Ampicillin and 1 inappropriate indication 
cloxacillin 
285 dermatitis or Cloxacillin 1 inappropriate indication 
atopic eczema 
286 Ampicillin + 1 inappropriate indication 
cloxacillin 
287 phlebitis Cloxacillin 1 inappropriate indication 
288 viral infection Cefliroxime 1 inappropriate indication 
289 obstructive Cefuroxime 1 inappropriate indication 
jaundice 
290 ascites Ampicillin- 1 inappropriate indication 
sulbactam 
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Therapy Indication Antibiotic No. of Appropriateness Type of 
no. prescribed therapies inappropriate 
use 
291 cerebrovascular Cefliroxime 1 inappropriate indication 
accident 
292 Ampicillin- 1 inappropriate indication 
sulbactam 
293 hypothermia Cefuroxime + 1 inappropriate indication 
cloxacillin 
294 hyperglycaemia Cefuroxime 1 inappropriate indication 
295 diabetic Cefuroxime 1 inappropriate indication 
ketoacidosis 
296 osteoarthritis of Cefliroxime 1 inappropriate indication 
knee 
297 knee pain Cefuroxime 1 inappropriate indication 
298 wound pain Cefuroxime 1 inappropriate indication 
299 chill and rigor Ampicillin- 1 inappropriate indication 
after operation sulbactam 
300 heart failure with Ampicillin- 1 inappropriate indication 
fluid retention sulbactam 
301 sedimentation Cefliroxime 1 inappropriate indication 
from PCN site 
swab 
302 drug overdose Cefuroxime 1 inappropriate indication 
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Therapy Indication Antibiotic No. of Appropriateness Type of 
no. prescribed therapies inappropriate 
use 
303 convulsion and Cefuroxime 1 inappropriate indication 
fever 
304 raised white cell Cefuroxime 1 inappropriate indication 
count 
305 Ampicillin- 1 inappropriate indication 
sulbactam 
306-307 poor general Cefuroxime 2 inappropriate indication 
condition or low 
oral intake 
308 fever after Cefuroxime 1 inappropriate indication 
discharge from 
intensive care unit 
309-310 fever after Cefuroxime 2 inappropriate indication 
admission 
311 dizziness in Ceftazidime 1 inappropriate indication 
leukaemic patient 
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Therapy Antibiotic Sample Pathogen Resistance of Sensitivity of Appropriateness 
no. pathogen pathogen 





313 Cefuroxime MSU E. coli Ampicillin, Cefuroxime, appropriate 
CO- co-amoxiclav, 
trimoxazole netilmicin 
314 Ampicillin CSU enterococcus - Ampicillin appropriate 
315 Ofloxacin CSU Group B - Ampicillin, inappropriate^^ 
Streptococci co-
trimoxazole 
316- Amoxycillin + - Helicobacter - - appropriate 
321 clarithromycin pylori 
322 Metronidazole - Helicobacter - - inappropriate 
+ tetracycline pylori 
323- Clarithromycin - Helicobacter - - inappropriate 
324 
pylori 
22 Cefiiroxime is delivered to the urinary tract in active form. 
23 Ofloxacin is an inappropriate choice. Susceptibility test results is useful to determine appropriate 
antibiotics. 
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Appendix 3 Culture test results in an audit of use of antibiotics in a medical ward 
Specimen Results Frequency negative results 
Sputum Haemophilus influenzae 4 -
AFB -ve 45 45 
AFB +ve 1 -
Pseiidomonas aeruginosa 5 -
Streptococcus pneumoniae 3 -
Candida albicans 1 “ 
yeast 1 “ 
P-lactamase +ve Moraxella catarrhal is 1 “ 
Staphylococcus aureus 1 “ 
Klebsiella species 2 -
MRSA 2 -
Actinobacillus colonization 1 -
no growth 5 5 
epithelial cell 2 2 
oral commensal 13 13 
normal flora 1 1 
subtotal 88 66 
urine Escherichia coli 9 “ 
Candida albicans 1 “ 
mixed bacterial flora 2 -
Proteus mirabilis 3 “ 
Klebsiella species 2 -
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Specimen Results Frequency negative results 
urine Pseudomonas aeruginosa 3 -
Enterobacter species 2 -
enterococcus 1 “ 
Group B Streptococci 1 -
no growth 18 18 
red blood cell 1 1 
AFB -ve 2 2 
subtotal 45 21 
blood Escherichia coli ^ ‘ 
coagulase —ve Staphylococci 5 -
no growth 10 10 
Anti-HAV IgM -ve 1 1 
Anti-HBc IgM -ve 1 1 
HCV - v e 1 1 
HBsAg -ve 5 5 
salmonella typhi type “0” -ve 1 1 
salmonella typhi type “H，，-ve 1 1 
salmonella paratyphi A -ve 1 1 
salmonella paratyphi B -ve 1 1 
salmonella paratyphi C -ve 1 1 
infectious mononucleosis -ve 1 丄 
subtotal 24 
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Specimen Results Frequency negative results 
ascitic fluid no growth 1 1 
AFB -ve 1 1 
throat swab oral commensal 1 1 
pleural mycobacteria 1 “ 
biopsy 
tracheal Klebsiella species 1 “ 
aspirate 
bile Escherichia coli 1 一 
Klebsiella species 1 “ 
pleural Gram +ve cocci 1 ‘ 
aspirate 
Streptococcus mutans 1 “ 
Proteus mirahilis 1 ‘ 
no growth 1 1 
AFB -ve 2 2 
TB aspirate AFB -ve 1 ^ 
bronchial no growth 1 1 
aspirate 
AFB-ve 2 2 
oral commensal 1 1 
PCN site no growth 1 1 
swab 
Citrobacter species 1 “ 
subtotal 20 12 
“ ^ ^ 
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Appendix 4 Generic to trade name conversion of antibiotics 
Generic name of antibiotic Trade name(s) of antibiotic 
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